Healthcare Services (HCSG) 10-Q 22 Apr 22 2022 Q1 Quarterly report Financial data

Cover Page

Cover Page - shares	3 Months Ended
	Mar. 31, 2022	Apr. 20, 2022
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2022
Document Transition Report	false
Entity File Number	0-12015
Entity Registrant Name	HEALTHCARE SERVICES GROUP, INC.
Entity Incorporation, State Code	PA
I.R.S. Employer Identification No.	23-2018365
Entity Address, Address Line One	3220 Tillman Drive
Entity Address, Address Line Two	Suite 300
Entity Address, City or Town	Bensalem
Entity Address, State or Province	PA
Entity Address, Postal Zip Code	19020
City Area Code	215
Local Phone Number	639-4274
Title of 12(b) Security	Common Stock, $.01 par value
Trading Symbol	HCSG
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		74,036,000
Entity Central Index Key	0000731012
Amendment Flag	false
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--12-31

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 32,899	$ 70,794
Marketable securities, at fair value	107,171	114,396
Accounts and notes receivable, less allowance for doubtful accounts of $57,784 and $59,271 as of March 31, 2022 and December 31, 2021, respectively	319,095	293,388
Inventories and supplies	24,820	26,015
Taxes receivable	5,049	8,813
Prepaid expenses and other assets	35,793	32,976
Total current assets	524,827	546,382
Property and equipment, net	26,702	28,102
Goodwill	75,529	74,755
Other intangible assets, less accumulated amortization of $29,097 and $27,879 as of March 31, 2022 and December 31, 2021, respectively	19,587	20,805
Notes receivable – long–term portion, less allowance for doubtful accounts of $5,308 and $6,312 as of March 31, 2022 and December 31, 2021, respectively	27,923	29,259
Deferred compensation funding, at fair value	39,012	46,691
Deferred tax asset	32,936	31,535
Total assets	746,516	777,529
Current liabilities:
Accounts payable	64,037	64,419
Accrued payroll and related taxes	42,160	68,664
Other accrued expenses	26,497	26,741
Borrowings under line of credit	10,000	0
Deferred compensation liability — short-term	6,294	6,991
Accrued insurance claims	25,316	24,310
Total current liabilities	174,304	191,125
Accrued insurance claims — long-term	67,134	65,084
Deferred compensation liability — long-term	39,157	46,888
Lease liability — long-term	10,588	11,299
Other long-term liabilities	8,696	10,456
Commitments and contingencies (Note 15)
STOCKHOLDERS’ EQUITY:
Common stock, $0.01 par value; 100,000 shares authorized; 76,158 and 76,009 shares issued, and 74,036 and 73,769 shares outstanding as of March 31, 2022 and December 31, 2021, respectively	762	760
Additional paid-in capital	296,304	294,124
Retained earnings	179,427	183,957
Accumulated other comprehensive (loss) income, net of taxes	(1,269)	4,000
Common stock in treasury, at cost, 2,122 and 2,240 shares as of March 31, 2022 and December 31, 2021, respectively	(28,587)	(30,164)
Total stockholders’ equity	446,637	452,677
Total liabilities and stockholders’ equity	$ 746,516	$ 777,529

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Allowance for doubtful accounts, current	$ 57,784	$ 59,271
Accumulated amortization of other intangible assets	29,097	27,879
Allowance for doubtful accounts, noncurrent	$ 5,308	$ 6,312
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock authorized (in shares)	100,000,000	100,000,000
Common stock issued (in shares)	76,158,000	76,009,000
Common stock outstanding (in shares)	74,036,000	73,769,000
Common stock in treasury (in shares)	2,122,000	2,240,000

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Income Statement [Abstract]
Revenues	$ 426,811	$ 407,751
Operating costs and expenses:
Costs of services provided	373,262	336,619
Selling, general and administrative expense	35,736	39,987
Other (expense) income:
Investment and other (loss) income, net	(1,523)	2,165
Interest expense	(509)	(358)
Income before income taxes	15,781	32,952
Income tax provision	4,452	8,299
Net income	$ 11,329	$ 24,653
Per share data:
Basic earnings per share (in dollars per share)	$ 0.15	$ 0.33
Diluted earnings per share (in dollars per share)	$ 0.15	$ 0.33
Weighted average number of common shares outstanding:
Basic (in shares)	74,326	75,003
Diluted (in shares)	74,333	75,224
Comprehensive income:
Net income	$ 11,329	$ 24,653
Other comprehensive loss:
Unrealized loss on available-for-sale marketable securities, net of taxes	(5,269)	(1,271)
Total comprehensive income	$ 6,060	$ 23,382

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Cash flows from operating activities:
Net income	$ 11,329	$ 24,653
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	4,147	3,607
Bad debt provision	2,851	3,415
Share-based compensation expense	2,396	2,271
Amortization of premium on marketable securities	561	536
Unrealized loss (gain) on deferred compensation fund investments	4,074	(1,146)
Changes in other long-term liabilities	(1,760)	0
Net loss on disposals of fixed assets	173	268
Changes in operating assets and liabilities:
Accounts and notes receivable	(27,222)	1,903
Inventories and supplies	1,195	2,416
Prepaid expenses and other assets	(2,462)	(19,814)
Deferred compensation funding	3,605	990
Accounts payable and other accrued expenses	(3,051)	6,064
Accrued payroll, accrued and withheld payroll taxes	(24,933)	(30,747)
Income taxes receivable	3,764	7,908
Accrued insurance claims	3,056	622
Deferred compensation liability	(7,905)	556
Net cash (used in) provided by operating activities	(30,182)	3,502
Cash flows from (used in) investing activities:
Disposals of fixed assets	152	54
Additions to property and equipment	(1,407)	(850)
Purchases of marketable securities	(1,525)	(7,902)
Sales of marketable securities	1,519	4,995
Cash paid for acquisitions	(114)	0
Net cash used in investing activities	(1,375)	(3,703)
Cash flows from financing activities:
Dividends paid	(15,704)	(15,472)
Reissuance of treasury stock pursuant to Dividend Reinvestment Plan	25	23
Proceeds from the exercise of stock options	410	1,475
Proceeds from short-term borrowings	10,000	0
Payments of statutory withholding on net issuance of restricted stock units	(1,069)	(1,501)
Net cash used in financing activities	(6,338)	(15,475)
Net change in cash and cash equivalents	(37,895)	(15,676)
Cash and cash equivalents at beginning of the period	70,794	139,330
Cash and cash equivalents at end of the period	$ 32,899	$ 123,654

Consolidated Statements of Stoc

Consolidated Statements of Stockholders' Equity - USD ($) shares in Thousands, $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Other Comprehensive Income, net of taxes	Retained Earnings	Treasury Stock
Beginning balance (in shares) at Dec. 31, 2020		75,798
Beginning balance at Dec. 31, 2020	$ 480,461	$ 758	$ 282,206	$ 5,563	$ 200,893	$ (8,959)
Comprehensive income:
Net income	24,653				24,653
Unrealized gain (loss) on available-for-sale marketable securities, net of taxes	(1,271)			(1,271)
Total comprehensive income	23,382
Exercise of stock options and other share-based compensation, net of shares tendered for payment (in shares)		156
Exercise of stock options and other share-based compensation, net of shares tendered for payment	1,475	$ 2	1,473
Payment of statutory withholding on issuance of restricted stock units	(1,501)		(1,501)
Share-based compensation expense	2,104		2,104
Treasury shares issued for Deferred Compensation Plan funding and redemptions	509		545			(36)
Shares issued pursuant to Employee Stock Plan	2,052		1,554			498
Dividends paid and accrued	(15,526)				(15,526)
Shares issued pursuant to Dividend Reinvestment Plan	23		18			5
Other (in shares)		4
Other	123		123
Ending balance (in shares) at Mar. 31, 2021		75,958
Ending balance at Mar. 31, 2021	493,102	$ 760	286,522	4,292	210,020	(8,492)
Beginning balance (in shares) at Dec. 31, 2021		76,009
Beginning balance at Dec. 31, 2021	452,677	$ 760	294,124	4,000	183,957	(30,164)
Comprehensive income:
Net income	11,329				11,329
Unrealized gain (loss) on available-for-sale marketable securities, net of taxes	(5,269)			(5,269)
Total comprehensive income	6,060
Exercise of stock options and other share-based compensation, net of shares tendered for payment (in shares)		145
Exercise of stock options and other share-based compensation, net of shares tendered for payment	410	$ 2	408
Payment of statutory withholding on issuance of restricted stock units	(1,069)		(1,069)
Share-based compensation expense	2,298		2,298
Treasury shares issued for Deferred Compensation Plan funding and redemptions	524		110			414
Shares issued pursuant to Employee Stock Plan	1,512		368			1,144
Dividends paid and accrued	(15,859)				(15,859)
Shares issued pursuant to Dividend Reinvestment Plan	25		6			19
Other (in shares)		4
Other	59		59
Ending balance (in shares) at Mar. 31, 2022		76,158
Ending balance at Mar. 31, 2022	$ 446,637	$ 762	$ 296,304	$ (1,269)	$ 179,427	$ (28,587)

Consolidated Statements of St_2

Consolidated Statements of Stockholders' Equity (Parenthetical) - $ / shares	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Statement of Stockholders' Equity [Abstract]
Cash dividend paid per common share (in dollars per share)	$ 0.21	$ 0.21

Description of Business and Sig

Description of Business and Significant Accounting Policies	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Description of Business and Significant Accounting Policies	Note 1—Description of Business and Significant Accounting Policies Nature of Operations Healthcare Services Group, Inc. (the “Company”) provides management, administrative and operating expertise and services to the housekeeping, laundry, linen, facility maintenance and dietary service departments of the healthcare industry, including nursing homes, retirement complexes, rehabilitation centers and hospitals located throughout the United States. Although the Company does not directly participate in any government reimbursement programs, the Company’s customers receive government reimbursements related to Medicare and Medicaid. Therefore, they are directly affected by any legislation relating to Medicare and Medicaid reimbursement programs. The Company provides services primarily pursuant to full service agreements with its customers. In such agreements, the Company is responsible for the day-to-day management of employees located at the customers’ facilities, as well as for the provision of certain supplies. The Company also provides services on the basis of management-only agreements for a limited number of customers. In a management-only agreement, the Company provides management and supervisory services while the customer facility retains payroll responsibility for the non-supervisory staff. The agreements with customers typically provide for a renewable one year service term, cancellable by either party upon 30 to 90 days’ notice after an initial period of 60 to 120 days. The Company is organized into two reportable segments: housekeeping, laundry, linen and other services (“Housekeeping”), and dietary department services (“Dietary”). Housekeeping consists of managing the customers’ housekeeping departments, which are principally responsible for the cleaning, disinfecting and sanitizing of resident rooms and common areas of a customer’s facility, as well as the laundering and processing of the bed linens, uniforms, resident personal clothing and other assorted linen items utilized at a customer facility. Dietary consists of managing the customers’ dietary departments, which are principally responsible for food purchasing, meal preparation and dietitian professional services, which includes the development of menus that meet residents’ dietary needs. Unaudited Interim Financial Data The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) for interim financial information and the requirements of Form 10-Q and Article 10 of Regulation S-X. Accordingly, these consolidated financial statements do not include all of the information and footnotes necessary for a complete presentation of financial position, results of operations and cash flows. However, in the Company’s opinion, all adjustments which are of a normal recurring nature and are necessary for a fair presentation have been reflected in these consolidated financial statements. The balance sheet shown in this report as of December 31, 2021 has been derived from the audited financial statements for the year ended December 31, 2021. These financial statements should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. The results of operations for the three months ended March 31, 2022 are not necessarily indicative of the results that may be expected for any future period. Use of Estimates in Financial Statements In preparing financial statements in conformity with U.S. GAAP, estimates and assumptions are made that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities, and the reported amounts of revenues and expenses. Actual results could differ from those estimates. Significant estimates are used in determining, but are not limited to, the Company’s allowance for doubtful accounts, accrued insurance claims, valuations, deferred taxes and reviews for potential impairment. The estimates are based upon various factors including current and historical trends, as well as other pertinent industry and regulatory authority information, including the potential future effects of COVID-19. Management regularly evaluates this information to determine if it is necessary to update the basis for its estimates and to adjust for known changes. Principles of Consolidation The accompanying consolidated financial statements include the accounts of Healthcare Services Group, Inc. and its wholly-owned subsidiaries. All significant intercompany transactions and balances have been eliminated in consolidation. Cash and Cash Equivalents Cash and cash equivalents are held in U.S. financial institutions or in custodial accounts with U.S. financial institutions. Cash equivalents are defined as short-term, highly liquid investments with a maturity of three months or less at time of purchase that are readily convertible into cash and have insignificant interest rate risk. Accounts and Notes Receivable Accounts and notes receivable consist of Housekeeping and Dietary segment trade receivables from contracts with customers. The Company’s payment terms with customers for services provided are defined within each customer’s service agreement. All accounts receivables are considered short term assets as the Company does not grant payment terms greater than one year. Accounts receivable initially are recorded at the transaction amount, and are recorded after the Company has an unconditional right to payment where only the passage of time is required before payment is received. Each reporting period, the Company evaluates the collectability of outstanding receivable balances and records an allowance for doubtful accounts representing an estimate of future expected credit loss. Additions to the allowance for doubtful accounts are made by recording a charge to bad debt expense reported in costs of services provided. Notes receivable are initially recorded when accounts receivable are transferred into a promissory note and are recorded as an alternative to accounts receivable to memorialize an unqualified promise to pay a specific sum, typically with interest, in accordance with a defined payment schedule. The Company’s payment terms with customers on promissory notes can vary based on several factors and the circumstances of each promissory note, however typically promissory notes mature over a 1 to 3 year period. Similar to accounts receivable, each reporting period the Company evaluates the collectability of outstanding notes receivable balances and records an allowance for doubtful accounts representing an estimate of future expected credit loss. Refer to Note 3—Accounts and Notes Receivable herein for further information. Allowance for Doubtful Accounts In accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification subtopic 326 Credit Losses - Measurement of Credit Losses on Financial Instruments (“ASC 326”), Management utilizes financial modeling to determine an allowance that reflects its best estimate of the lifetime expected credit losses on accounts and notes receivable which is recorded as a liability to offset the receivables. Modeling is prepared after considering historical experience, current conditions, and reasonable and supportable economic forecasts to estimate lifetime expected credit losses. Accounts and notes receivables are written off when deemed uncollectible. Recoveries of receivables previously written off are recorded as a reduction of bad debt expense when received. Refer to Note 4—Allowance for Doubtful Accounts herein for further information. Inventories and Supplies Inventories and supplies include housekeeping, linen and laundry supplies, as well as food provisions and supplies. Non-linen inventories and supplies are stated on a first-in, first-out (FIFO) basis, and reduced as deemed necessary to approximate the lower of cost or net realizable value. Linen supplies are amortized on a straight-line basis over their estimated useful life of 24 months. Revenue Recognition The Company recognizes revenue from contracts with customers when or as the promised goods and services are provided to customers. Revenues are reported net of sales taxes that are collected from customers and remitted to taxing authorities. The amount of revenue recognized by the Company is based on the consideration to which the Company is entitled in exchange for providing the contracted goods and services. Refer to Note 2—Revenue herein for further information. Leases The Company records assets and liabilities on the balance sheet to recognize the rights and obligations arising from leasing arrangements with contractual terms greater than 12 months, in accordance with FASB Accounting Standards Codification subtopic ASC 842 Leases (“ASC 842”). A leasing arrangement includes any contract which entitles the Company to the right of use of an identified tangible asset where there are no restrictions as to the direct of use of the asset, and the Company obtains substantially all of the economic benefits from the right of use. As of March 31, 2022 and December 31, 2021, the Company was only the lessee of operating lease arrangements. Refer to Note 7—Leases herein for further information. Income Taxes The Company uses the asset and liability method of accounting for income taxes. Under this method, income tax expense or benefits are recognized for the amount of taxes payable or refundable for the current period. The Company accrues for probable tax obligations as required, based on facts and circumstances in various regulatory environments. In addition, deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities. When appropriate, valuation allowances are recorded to reduce deferred tax assets to amounts for which realization is more likely than not. Uncertain income tax positions taken or expected to be taken in tax returns are reflected within the Company’s financial statements based on a recognition and measurement process. Earnings per Common Share Basic earnings per common share is computed by dividing income available to common shareholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per common share is computed using the weighted-average number of common shares outstanding and dilutive common shares, such as those issuable upon exercise of stock options and upon the vesting of restricted stock units. Share-Based Compensation The Company estimates the fair value of share-based awards on the date of grant using the Black-Scholes valuation model for stock options, using a Monte Carlo simulation for performance restricted stock units, and using the share price on the date of grant for restricted stock units and deferred stock units. The value of the award is recognized ratably as an expense in the Company’s Consolidated Statements of Comprehensive Income over the requisite service periods, with adjustments made for forfeitures as they occur. Identifiable Intangible Assets and Goodwill Identifiable intangible assets are amortized on a straight-line basis over their respective lives. Goodwill represents the excess of cost over the fair value of net assets of acquired businesses. Management reviews the carrying value of goodwill annually during the fourth quarter to assess for impairment, or more often if events or circumstances indicate that the carrying value may exceed its estimated fair value. No impairment loss was recognized on the Company's intangible assets or goodwill during the three months ended March 31, 2022 or 2021. Concentrations of Credit Risk The Company’s financial instruments that are subject to credit risk are cash and cash equivalents, marketable securities, deferred compensation funding and accounts and notes receivable. At March 31, 2022 and December 31, 2021, substantially all of the Company’s cash and cash equivalents and marketable securities were held in one large financial institution located in the United States. The Company’s marketable securities are fixed income investments which are highly liquid and can be readily purchased or sold through established markets. The Company’s customers are concentrated in the healthcare industry and are primarily providers of long-term care. The revenues of many of the Company’s customers are highly reliant on Medicare, Medicaid and third party payors’ reimbursement funding rates. New legislation or changes in existing regulations could directly impact the governmental reimbursement programs in which the customers participate. As a result, the Company may not realize the full effects of such programs until these laws are fully implemented and governmental agencies issue applicable regulations or guidance.

Revenue

Revenue	3 Months Ended
	Mar. 31, 2022
Revenue from Contract with Customer [Abstract]
Revenue	Note 2—Revenue The Company presents its consolidated revenues disaggregated by reportable segment, as Management evaluates the nature, amount, timing and uncertainty of the Company’s revenues by segment. Refer to Note 12—Segment Information herein as well as the information below regarding the Company’s reportable segments. Housekeeping Housekeeping accounted for $201.7 million and $215.1 million of the Company’s consolidated revenues for the three months ended March 31, 2022 and 2021, respectively, which represented approximately 47.3% and 52.7% of the Company’s revenues in each respective period. The Housekeeping services include managing customers’ housekeeping departments, which are principally responsible for the cleaning, disinfecting and sanitizing of resident rooms and common areas of the customers’ facilities, as well as the laundering and processing of the bed linens, uniforms, resident personal clothing and other assorted linen items utilized at the customers’ facilities. Upon beginning service with a customer facility, the Company will typically hire and train the employees previously employed by such facility and assign an on-site manager to supervise and train the front-line personnel and coordinate housekeeping services with other facility support functions in accordance with customer requests. Such management personnel also oversee the execution of various cost and quality-control procedures including continuous training and employee evaluation. Dietary Dietary services accounted for $225.1 million and $192.7 million of the Company’s consolidated revenues for the three months ended March 31, 2022 and 2021, respectively, which represented approximately 52.7% and 47.3% of the Company’s revenues in each respective period. Dietary services consist of managing customers’ dietary departments which are principally responsible for food purchasing, meal preparation and professional dietitian services, which include the development of menus that meet the dietary needs of residents. On-site management is responsible for all daily dietary department activities, with regular support provided by a District Manager specializing in dietary services. The Company also offers clinical consulting services to facilities which if contracted is a service bundled within the monthly service provided to customers. Upon beginning service with a customer facility, the Company will typically hire and train the employees previously employed by such facility and assign an on-site manager to supervise and train the front-line personnel and coordinate dietitian services with other facility support functions in accordance with customer requests. Such management personnel also oversee the execution of various cost and quality control procedures including continuous training and employee evaluation. Revenue Recognition The Company’s revenues are derived from contracts with customers. The Company accounts for revenue from contracts with customers in accordance with FASB Accounting Standards Codification subtopic ASC 606 Revenue from Contracts with Customers (“ASC 606”), and as such, the Company recognizes revenue to depict the transfer of promised goods and services to customers in amounts that reflect the consideration to which the Company is entitled in exchange for those goods and services. The Company’s costs of obtaining contracts are not material. The Company performs services and provides goods in accordance with its customers' contracts. Such contracts typically provide for a renewable one year service term, cancellable by either party upon 30 to 90 days’ notice, after an initial period of 60 to 120 days. A performance obligation is the unit of account under ASC 606 and is defined as a promise in a contract to transfer a distinct good or service to the customer. The Company’s Housekeeping and Dietary contracts relate to the provision of bundles of goods, services or both, which represent a series of distinct goods and services that are substantially the same and that have the same pattern of transfer to the customer. The Company accounts for the series as a single performance obligation satisfied over time, as the customer simultaneously receives and consumes the benefits of the goods and services provided. Revenue is recognized using the output method, which is based upon the delivery of goods and services to the customers’ facilities. In limited cases, the Company provides goods, services or both, before the execution of a written contract. In these cases, the Company defers the recognition of revenue until a contract is executed. The amount of such deferred revenue was $0.8 million and $0.1 million as of March 31, 2022 and December 31, 2021, respectively. Additionally, substantially all such revenue amounts deferred as of December 31, 2021 were subsequently recognized as revenue during the three months ended March 31, 2022. The transaction price is the amount of consideration to which the Company is entitled in exchange for transferring promised goods or services to its customers. The transaction price does not include taxes assessed or collected. The Company’s contracts detail the fees that the Company charges for the goods and services it provides. For certain contracts which contain a variable component to the transaction price, the Company is required to make estimates of the amount of consideration to which the Company will be entitled, based on variability in resident and patient populations serviced, product usage or quantities consumed. The Company recognizes revenue related to such estimates only when the Company determines that there will not be a significant reversal in the amount of revenue recognized. The Company’s contracts generally do not contain significant financing components, as payment terms are less than one year. The Company allocates the transaction price to each performance obligation, noting that the bundle of goods, services or goods and services provided under each Housekeeping and Dietary contract represent a single performance obligation satisfied over time. The Company recognizes the related revenue when it satisfies the performance obligation by transferring a bundle of promised goods, services or both to a customer. Such recognition is on a monthly or weekly basis, as goods are provided and services are performed. In some cases, the Company requires customers to pay in advance for goods and services to be provided. As of March 31, 2022 the value of the contract liabilities associated with customer prepayments was less than $0.1 million. As of December 31, 2021, the value of the contract liabilities associated with customer prepayments was $2.5 million. Additionally, substantially all such revenue amounts deferred as of December 31, 2021 were subsequently recognized as revenue during the three months ended March 31, 2022. Transaction Price Allocated to Remaining Performance Obligations The Company recognizes revenue as it satisfies the performance obligations associated with contracts with customers, which due to the nature of the goods and services provided by the Company, are satisfied over time. Contracts may contain transaction prices that are fixed, variable or both. The Company’s contracts with customers typically provide for an initial term of one year, with renewable one year service terms, cancellable by either party upon 30 to 90 days’ notice after an initial period of 60 to 120 days. At March 31, 2022, the Company had $187.0 million related to performance obligations that were unsatisfied or partially unsatisfied for which the Company expects to recognize revenue. The Company expects to recognize revenue on approximately 52.2% of the remaining performance obligations over the next 12 months, with the balance to be recognized thereafter. These amounts exclude variable consideration primarily related to performance obligations that consist of a series of distinct service periods with revenues based on future performance that cannot be estimated at contract inception. The Company also has elected to apply the practical expedient that permits exclusion of information about the remaining performance obligations with original expected durations of one year or less.

Accounts and Notes Receivable

Accounts and Notes Receivable	3 Months Ended
	Mar. 31, 2022
Receivables [Abstract]
Accounts and Notes Receivable	Note 3—Accounts and Notes Receivable The Company’s accounts and notes receivable balances consisted of the following as of March 31, 2022 and December 31, 2021: March 31, 2022 December 31, 2021 (in thousands) Short-term Accounts and notes receivable $ 376,879 $ 352,659 Allowance for doubtful accounts (57,784) (59,271) Total net short-term accounts and notes receivable $ 319,095 $ 293,388 Long-term Notes receivable $ 33,231 $ 35,571 Allowance for doubtful accounts (5,308) (6,312) Total net long-term notes receivable $ 27,923 $ 29,259 Total net accounts and notes receivable $ 347,018 $ 322,647 The Company makes credit decisions on a case-by-case basis after reviewing a number of qualitative and quantitative factors related to the specific customer as well as current industry variables that may impact that customer. There are a variety of factors that impact a customer’s ability to pay in accordance with the Company’s contracts. These factors include, but are not limited to, fluctuating census numbers, litigation costs and the customer’s participation in programs funded by federal and state governmental agencies. Deviations in the timing or amounts of reimbursements under those programs can impact the customer’s cash flows and its ability to make timely payments. However, the customer’s obligation to pay the Company in accordance with the contracts are not contingent upon the customer’s cash flow. Notwithstanding the Company’s efforts to minimize its credit risk exposure, the aforementioned factors, as well as other factors that impact customer cash flows or ability to make timely payments, could have an indirect, yet material adverse effect on the Company’s results of operations and financial condition. Fluctuations in net accounts and notes receivable are generally attributable to a variety of factors including, but not limited to, the timing of cash receipts from customers and the inception, transition, modification or termination of customer relationships. The Company deploys significant resources and has invested in tools and processes to optimize Management’s credit and collections efforts. When appropriate, the Company utilizes interest-bearing promissory notes to enhance the collectability of amounts due, by instituting definitive repayment plans and providing a means by which to further evidence the amounts owed. In addition, the Company may amend contracts from full service to management-only arrangements, or adjust contractual payment terms, to accommodate customers who have in good faith established clearly-defined plans for addressing cash flow issues. These efforts are intended to minimize the Company’s collections risk.

Allowance for Doubtful Accounts

Allowance for Doubtful Accounts	3 Months Ended
	Mar. 31, 2022
Receivables [Abstract]
Allowance for Doubtful Accounts	Note 4—Allowance for Doubtful Accounts In making the Company’s credit evaluations, management considers the general collection risk associated with trends in the long-term care industry. The Company establishes credit limits through payment terms with customers, performs ongoing credit evaluations and monitors accounts on an aging schedule basis to minimize the risk of loss. Despite the Company’s efforts to minimize credit risk exposure, customers could be adversely affected if future industry trends, including those related to COVID-19, change in such a manner as to negatively impact their cash flows. The full effects of COVID-19 on the Company’s customers are highly uncertain and cannot be predicted. As a result, the Company’s future collection experience can differ significantly from historical collection trends. If the Company’s customers experience a negative impact on their cash flows, it could have a material adverse effect on the Company’s results of operations and financial condition. The Company evaluates its accounts and notes receivable for expected credit losses quarterly. Accounts receivables are evaluated based on internally developed credit quality indicators derived from the aging of receivables. Notes receivable are evaluated based on internally developed credit quality indicators derived from Management’s assessment of collection risk. The Company manages note receivable portfolios using a two tiered approach by disaggregating standard notes receivables, which are promissory notes in good standing, from those who have been identified by Management as having an elevated credit risk profile due to a triggering event such as bankruptcy. At the end of each period, the Company sets a reserve for expected credit losses on standard notes receivable based on the Company’s historical loss rate. Notes receivable with an elevated risk profile, which are from customers who have filed bankruptcy, are subject to collections activity or are slow payers that are experiencing financial difficulties, are aggregated and evaluated to determine the total reserve for the class of receivable. The guidance in ASC 326 permits entities to make an accounting policy election not to measure an estimate for credit losses on accrued interest if those entities write-off accrued interest deemed uncollectible in a timely manner. The Company follows an income recognition policy on all interest earned on notes receivable. Under such policy the Company accounts for all notes receivable on a non-accrual basis and defers the recognition of any interest income until receipt of cash payments. This policy was established, recognizing the environment of the long-term care industry, and not because such notes receivable are necessarily impaired. Accordingly, the Company does not record a credit loss adjustment for accrued interest. Interest income from notes receivable for the three months ended March 31, 2022 and 2021 was $0.3 million and $0.4 million, respectively. As part of the Company’s adoption of ASC 326, there are additional disclosures required to be made on a class of financing receivable basis. The following table presents the Company’s two tiers of notes receivable further disaggregated by year of origination, as well as write-off activity for the three months ended March 31, 2022. Notes Receivable Amortized Cost Basis by Origination Year 2022 2021 2020 2019 2018 Prior Total (in thousands) Notes Receivable Standard notes receivable $ 486 $ 15,461 $ 5,588 $ 272 $ 18,715 $ 22,842 $ 63,364 Elevated risk notes receivable $ — $ — $ — $ — $ — $ 1,715 $ 1,715 Current-period gross write-offs $ — $ — $ — $ — $ — $ — $ — Current-period recoveries — — — — — — — Current-period net write-offs $ — $ — $ — $ — $ — $ — $ — The following table provides information as to the status of payment on the Company’s notes receivable which were past due as of March 31, 2022: Age Analysis of Past-Due Notes Receivable as of March 31, 2022 0 - 90 Days 91 - 180 Days Greater than 181 Days Total (in thousands) Notes Receivable Standard notes receivable $ 1,030 $ 608 $ 12,176 $ 13,814 Elevated risk notes receivable — — 1,715 1,715 $ 1,030 $ 608 $ 13,891 $ 15,529 The following tables provide a summary of the changes in the Company’s allowance for doubtful accounts on a portfolio segment basis for the three months ended March 31, 2022 and 2021. Allowance for doubtful accounts Portfolio Segment: December 31, Write-Offs 1 Bad Debt Expense March 31, (in thousands) Accounts Receivables $ 50,794 $ (5,343) $ 3,960 $ 49,411 Notes Receivables Standard notes receivable $ 13,607 $ — $ (1,065) $ 12,542 Elevated risk notes receivable 1,183 — (44) 1,139 Total notes receivable $ 14,790 $ — $ (1,109) $ 13,681 Total accounts and notes receivable $ 65,584 $ (5,343) $ 2,851 $ 63,092 1. Write-offs are shown net of recoveries. During the three months ended March 31, 2022, the Company collected $0.2 million of accounts receivables and notes receivables which had previously been written-off as uncollectible. Allowance for doubtful accounts Portfolio Segment: December 31, Write-Offs 1 Bad Debt Expense March 31, (in thousands) Accounts Receivables $ 51,052 $ (7,305) $ 2,779 $ 46,526 Notes Receivables Standard notes receivable $ 13,258 $ (9) $ (256) $ 12,993 Elevated risk notes receivable 3,491 (2,800) 892 1,583 Total notes receivable $ 16,749 $ (2,809) $ 636 $ 14,576 Total Accounts and notes receivable $ 67,801 $ (10,114) $ 3,415 $ 61,102 1. Write-offs are shown net of recoveries. During the three months ended March 31, 2021, the amount of such recoveries was not material.

Changes in Accumulated Other Co

Changes in Accumulated Other Comprehensive Income by Component	3 Months Ended
	Mar. 31, 2022
Equity [Abstract]
Changes in Accumulated Other Comprehensive Income by Component	Note 5—Changes in Accumulated Other Comprehensive Income by Component The Company's accumulated other comprehensive income consists of unrealized gains and losses from the Company’s available-for-sale marketable securities. The following table provides a summary of the changes in accumulated other comprehensive income for the three months ended March 31, 2022 and 2021: Unrealized Gains and Losses on Available-for-Sale Securities 1 Three Months Ended March 31, 2022 2021 (in thousands) Accumulated other comprehensive income — beginning balance $ 4,000 $ 5,563 Other comprehensive loss before reclassifications (5,277) (1,307) Losses reclassified from other comprehensive income 2 8 36 Net current period other comprehensive loss 3 (5,269) (1,271) Accumulated other comprehensive (loss) income — ending balance $ (1,269) $ 4,292 1. All amounts are net of tax 2. Realized gains and losses were recorded pre-tax under “Investment and other income” in the Consolidated Statements of Comprehensive Income. For the three months ended March 31, 2022 and 2021, the Company recorded less than $0.1 million of realized losses from the sale of available-for-sale securities. Refer to Note 9—Fair Value Measurements herein for further information. 3. For the three months ended March 31, 2022 and 2021, the changes in other comprehensive income were net of a tax benefit of $1.4 million and $0.3 million, respectively. Amounts Reclassified from Accumulated Other Comprehensive Income 2022 2021 (in thousands) Three Months Ended March 31, Losses from the sale of available-for-sale securities $ (12) $ (48) Tax benefit 4 12 Net loss reclassified from accumulated other comprehensive income $ (8) $ (36)

Property and Equipment

Property and Equipment	3 Months Ended
	Mar. 31, 2022
Property, Plant and Equipment [Abstract]
Property and Equipment	Note 6—Property and Equipment Property and equipment are recorded at cost. Depreciation is recorded over the estimated useful life of each class of depreciable asset, and is computed using the straight-line method. Leasehold improvements are amortized over the shorter of the estimated asset life or term of the lease. Repairs and maintenance costs are charged to expense as incurred. The following table sets forth the amounts of property and equipment by each class of depreciable asset as of March 31, 2022 and December 31, 2021: March 31, 2022 December 31, 2021 (in thousands) Housekeeping and dietary equipment $ 13,614 $ 13,468 Computer hardware and software 5,976 5,880 Operating lease — right-of-use assets 33,446 33,217 Other 1 1,680 1,736 Total property and equipment, at cost 54,716 54,301 Less accumulated depreciation 28,014 26,199 Total property and equipment, net $ 26,702 $ 28,102 1. Includes furniture and fixtures, leasehold improvements and autos and trucks including auto leases. Depreciation expense for the three months ended March 31, 2022 and 2021 was $2.9 million and $2.6 million, respectively. Of the depreciation expense recorded for the three months ended March 31, 2022 and 2021, $1.6 million and $1.5 million related to the depreciation of the Company’s operating lease - right-of-use assets ( “

Leases

Leases	3 Months Ended
	Mar. 31, 2022
Leases [Abstract]
Leases	Note 7—Leases The Company recognizes ROU Assets and lease liabilities (“Lease Liabilities”) for automobiles, office buildings, IT equipment, and small storage units for the temporary storage of operational equipment. The Company’s leases have remaining lease terms ranging from less than 1 year to 7 years, and have extension options ranging from 1 year to 5 years. Most leases include the option to terminate the lease within 1 year. Upon adopting ASC 842, the Company made accounting policy elections using practical expedients offered under the guidance to combine lease and non-lease components within leasing arrangements and to recognize the payments associated with short-term leases in earnings on a straight-line basis over the lease term, with the cost associated with variable lease payments recognized when incurred. These accounting policy elections impact the value of the Company’s ROU Assets and Lease Liabilities. The value of the Company’s ROU Assets is determined as the non-depreciated fair value of its leasing arrangements and is recorded to “Property and equipment, net” on the Company’s Consolidated Balance Sheets. The value of the Company’s Lease Liabilities is the present value of fixed lease payments not yet paid, discounted using either the rate implicit in the lease contract if that rate can be determined, or the Company’s incremental borrowing rate ( “ IBR”) and is recorded in “Other accrued expenses” and “Lease liability — long-term portion” on the Company’s Consolidated Balance Sheets. The Company’s IBR is determined as the rate of interest that the Company would have to pay to borrow on a collateralized basis over a similar term in an amount equal to the lease payments in a similar economic environment. Any future lease payments that are not fixed based on the terms of the lease contract, or fluctuate based on a factor other than an index or rate, are considered variable lease payments and are not included in the value of the Company’s ROU Assets or Lease Liabilities. The Company's variable lease payments are mostly incurred from automobile leases and relate to miscellaneous transportation costs including repair costs, insurance, and terminal rental adjustments payments due at lease settlement. Such rental adjustment payments can result in a reduction to the Company's total variable lease payments. Components of lease expense required by ASC 842 are presented below for the three months ended March 31, 2022 and 2021. Three Months Ended March 31, 2022 2021 (in thousands) Lease cost Operating lease cost $ 1,386 $ 1,439 Short-term lease cost 355 167 Variable lease cost 82 72 Total lease cost $ 1,823 $ 1,678 Supplemental information required by ASC 842 is presented below for the three months ended March 31, 2022 and 2021. Three Months Ended March 31, 2022 2021 (dollar amounts in thousands) Other information Cash paid for amounts included in the measurement of lease liabilities Operating cash flows from operating leases $ 1,711 $ 1,583 Weighted-average remaining lease term — operating leases 4.4 years 5.6 years Weighted-average discount rate — operating leases 4.2 % 4.2 % During the three months ended March 31, 2022 and 2021, the Company’s ROU Assets and Lease Liabilities were reduced by $0.9 million and $0.2 million, respectively, due to lease cancellations. The following is a schedule by calendar year of future minimum lease payments under operating leases that have remaining terms as of March 31, 2022: Period/Year Operating Leases (in thousands) April 1 to December 31, 2022 $ 4,634 2023 4,956 2024 3,119 2025 1,396 2026 1,337 2027 1,363 Thereafter 1,505 Total minimum lease payments $ 18,310 Less: imputed lease payments 1,703 Present value of lease liabilities $ 16,607

Goodwill and Other Intangible A

Goodwill and Other Intangible Assets	3 Months Ended
	Mar. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill and Other Intangible Assets	Note 8—Goodwill and Other Intangible Assets Goodwill During the three months ended March 31, 2022, the Company’s goodwill increased $0.7 million due to a measurement period adjustment pertaining to the prior year acquisition of a regional dining operator. As of March 31, 2022, the Company has finalized its acquisition accounting for this transaction. Intangible Assets The Company’s other intangible assets consist of customer relationships, trade names, patents, and non-compete agreements which were obtained through acquisitions and are recorded at their fair values at the date of acquisition. Intangible assets with determinable lives are amortized on a straight-line basis over their estimated useful lives. The weighted-average amortization period of customer relationships, trade names, patents, and non-compete agreements are approximately 10 years, 13 years, 8 years, and 4 years, respectively. The following table sets forth the estimated amortization expense for intangibles subject to amortization for the remainder of 2022, the following five fiscal years and thereafter: Period/Year Total Amortization Expense (in thousands) April 1 to December 31, 2022 $ 3,642 2023 $ 3,819 2024 $ 2,685 2025 $ 2,685 2026 $ 2,665 2027 $ 1,196 Thereafter $ 2,895

Fair Value Measurements

Fair Value Measurements	3 Months Ended
	Mar. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	Note 9—Fair Value Measurements The Company’s current assets and current liabilities are financial instruments and most of these items (other than marketable securities, inventories and the short-term portion of deferred compensation funding) are recorded at cost in the Consolidated Balance Sheets. The estimated fair value of these financial instruments approximates their carrying value due to their short-term nature. The carrying value of the Company’s line of credit represents the outstanding amount of the borrowings, which approximates fair value. The Company’s financial assets that are measured at fair value on a recurring basis are its marketable securities and deferred compensation funding. The recorded values of all of the financial instruments approximate their current fair values because of their nature, stated interest rates and respective maturity dates or durations. The Company’s marketable securities are held by the Company’s captive insurance company to satisfy capital requirements of the state regulator related to captive insurance companies. Such securities primarily consist of tax-exempt municipal bonds, which are classified as available-for-sale and are reported at fair value. Unrealized gains and losses associated with these investments are included in “Unrealized loss on available-for-sale marketable securities, net of taxes” within the Consolidated Statements of Comprehensive Income. The fair value of these marketable securities is classified within Level 2 of the fair value hierarchy, as these securities are measured using quoted prices for identical or similar instruments in markets that are not active, and model-based valuation techniques for which all significant assumptions are observable. Such valuations are determined by a third-party pricing service. For the three months ended March 31, 2022 and 2021, the Company recorded unrealized losses, net of taxes of $5.3 million and $1.3 million on marketable securities, respectively. As part of the Company’s completed acquisition of a manufacturer of prepackaged meals in 2021, the Company used an analysis of the discounted weighted-average cost of capital attributable to the acquired company’s revenue (an income approach) to value the contingent consideration liability. The inputs utilized in estimating the fair value of the contingent consideration have been classified as Level 3 in the fair value hierarchy levels and are subject to risk and uncertainty. The discounted weighted-average cost of capital attributable to the acquired company’s revenue analysis is dependent on several subjective factors including future earnings, volatility and the discount rate. If assumptions vary from what was expected, the fair value of the contingent consideration liability may materially change. As of March 31, 2022 and December 31, 2021, the fair value of the contingent consideration liability was $3.1 million and $4.8 million, respectively, and were presented in “Other long-term liabilities” on the Company’s Consolidated Balance Sheets. For the three months ended March 31, 2022, the Company recorded a gain of $1.7 million from the fair value adjustment in “Other income – Investment and other income, net” in the Consolidated Statements of Comprehensive Income. No such gain or loss was recorded during the three months ended March 31, 2021. For the three months ended March 31, 2022 and 2021, the Company received total proceeds, less the amount of interest received, of $1.5 million and $5.0 million, respectively, from sales of available-for-sale municipal bonds. For both the three months ended March 31, 2022 and 2021, these sales resulted in realized losses of less than $0.1 million, which were recorded in “Other income – Investment and other income, net” in the Consolidated Statements of Comprehensive Income. The basis for the sale of these securities was the specific identification of each bond sold during the period. The investments under the funded deferred compensation plan are classified as trading securities and unrealized gains or losses are recorded in “Selling, general and administrative expense” in the Consolidated Statements of Comprehensive Income. The fair value of these investments are determined based on quoted market prices (Level 1). For the three months ended March 31, 2022 and 2021, the Company recognized unrealized losses of $4.1 million and unrealized gains of $1.1 million, respectively, related to equity securities still held at the respective reporting dates. The following tables provide fair value measurement information for the Company’s marketable securities and deferred compensation fund investments as of March 31, 2022 and December 31, 2021: As of March 31, 2022 Fair Value Measurement Using: Carrying Amount Total Fair Value Quoted Prices in Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Financial Assets: Marketable securities Municipal bonds — available-for-sale $ 107,171 $ 107,171 $ — $ 107,171 $ — Deferred compensation fund Money Market 1 $ 2,428 $ 2,428 $ — $ 2,428 $ — Balanced and Lifestyle 12,194 12,194 12,194 — — Large Cap Growth 16,206 16,206 16,206 — — Small Cap Growth 5,174 5,174 5,174 — — Fixed Income 4,414 4,414 4,414 — — International 1,719 1,719 1,719 — — Mid Cap Growth 3,171 3,171 3,171 — — Deferred compensation fund 2 $ 45,306 $ 45,306 $ 42,878 $ 2,428 $ — As of December 31, 2021 Fair Value Measurement Using: Carrying Total Fair Quoted Prices in Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Financial Assets: Marketable securities Municipal bonds — available-for-sale $ 114,396 $ 114,396 $ — $ 114,396 $ — Deferred compensation fund Money Market 1 $ 2,882 $ 2,882 $ — $ 2,882 $ — Balanced and Lifestyle 12,578 12,578 12,578 — — Large Cap Growth 20,358 20,358 20,358 — — Small Cap Growth 6,561 6,561 6,561 — — Fixed Income 4,826 4,826 4,826 — — International 2,299 2,299 2,299 — Mid Cap Growth 4,179 4,179 4,179 — — Deferred compensation fund 2 $ 53,683 $ 53,683 $ 50,801 $ 2,882 $ — 1. The fair value of the money market fund is based on the net asset value (“NAV”) of the shares held by the plan at the end of the period. The money market fund includes short-term United States dollar denominated money market instruments and the NAV is determined by the custodian of the fund. The money market fund can be redeemed at its NAV at the measurement date as there are no significant restrictions on the ability to sell this investment. 2. As of March 31, 2022 and December 31, 2021, $6.3 million and $7.0 million of short-term deferred compensation funding is included in “Prepaid expenses and other assets” on the Company's Consolidated Balance Sheets, respectively. Such amounts of short-term deferred compensation funding represent investments expected to be liquidated and paid to former employees within 12 months of employment termination. Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Credit Impairment Losses 1 (in thousands) March 31, 2022 Type of security: Municipal bonds — available-for-sale $ 108,778 $ 1,141 $ (2,748) $ 107,171 $ — Total debt securities $ 108,778 $ 1,141 $ (2,748) $ 107,171 $ — December 31, 2021 Type of security: Municipal bonds — available-for-sale $ 109,331 $ 5,219 $ (154) $ 114,396 $ — Total debt securities $ 109,331 $ 5,219 $ (154) $ 114,396 $ — 1. The Company performs a quarterly credit impairment loss assessment quarterly on an individual security basis. As of March 31, 2022 and December 31, 2021, no allowance for credit loss impairment has been recognized as the issuers of these securities have not established a cause for default and various rating agencies have reaffirmed each security's investment grade status. The fair value of these securities have fluctuated since the purchase date as market interest rates fluctuate. The Company does not intend to sell these securities and it is more likely than not that the Company will not be required to sell before the recovery of the securities' amortized cost basis. The following table summarizes the contractual maturities of debt securities held at March 31, 2022 and December 31, 2021, which are classified as “Marketable securities, at fair value” in the Consolidated Balance Sheets: Municipal Bonds — Available-for-Sale Contractual maturity: March 31, 2022 December 31, 2021 (in thousands) Maturing in one year or less $ 4,290 $ 5,606 Maturing in second year through fifth year 28,031 23,054 Maturing in sixth year through tenth year 44,174 52,180 Maturing after ten years 30,676 33,556 Total debt securities $ 107,171 $ 114,396

Share-Based Compensation

Share-Based Compensation	3 Months Ended
	Mar. 31, 2022
Share-based Payment Arrangement [Abstract]
Share-Based Compensation	Note 10—Shared-Based Compensation The components of the Company’s shared-based compensation expense for the three months ended March 31, 2022 and 2021 are as follows: Three Months Ended March 31, 2022 2021 (in thousands) Stock options $ 314 $ 458 Restricted stock and restricted stock units 1,785 1,550 Performance stock units 199 96 Employee Stock Purchase Plan 98 167 Total pre-tax share-based compensation expense charged against income 1 $ 2,396 $ 2,271 1. Share-based compensation expense is recorded in “C osts of services provided ” and “S elling, general and administrative expense ” on the Company’s Consolidated Statements of Comprehensive Income. At March 31, 2022, the unrecognized compensation cost related to unvested stock options and awards was $23.0 million. The weighted average period over which these awards will vest is approximately 3.5 years. 2020 Omnibus Incentive Plan On May 26, 2020, the Company adopted the 2020 Omnibus Incentive Plan (the “ 2020 Plan ” ) after approval by the Company's Shareholders at the Annual Meeting of Shareholders. The 2020 Plan provides that current or prospective officers, employees, non-employee directors and advisors can receive share-based awards such as stock options, performance stock units, restricted stock units and other stock awards. The 2020 Plan seeks to encourage profitability and growth of the Company through short-term and long-term incentives that are consistent with the Company's operating objectives. As of March 31, 2022, there were 4.7 million shares of common stock reserved for issuance under the 2020 Plan, of which, 1.3 million are available for future grant. The amount of shares available for issuance under the 2020 Plan will increase when outstanding awards under the Company's Second Amended and Restated 2012 Equity Incentive Plan (the “2012 Plan”) are subsequently forfeited, terminated, lapsed, or satisfied thereunder in cash or property other than shares. No stock award will have a term in excess of 10 years. The Nominating, Compensation and Stock Option Committee (the “NCSO”) of the Board of Directors is responsible for determining the terms of the grants in accordance with the 2020 Plan. Stock Options A summary of stock options outstanding under the 2020 Plan and the 2012 Plan as of December 31, 2021 and changes during the three months ended March 31, 2022 are as follows: Stock Options Outstanding Number of Shares Weighted Average Exercise Price (in thousands) December 31, 2021 2,181 $ 33.42 Granted 352 $ 18.10 Exercised (23) $ 17.50 Forfeited — $ — Expired (56) $ 21.68 March 31, 2022 2,454 $ 31.64 The weighted average grant-date fair value of stock options granted during the three months ended March 31, 2022 and 2021 was $4.06 and $7.01 per common share, respectively. The total intrinsic value of stock options exercised during the three months ended March 31, 2022 and 2021 was $0.1 million and $0.4 million, respectively. The fair value of stock option awards granted in 2022 and 2021 was estimated on the date of grant using the Black-Scholes option valuation model with the following assumptions: Three Months Ended March 31, 2022 2021 Risk-free interest rate 1.5 % 0.6 % Weighted average expected life 6.7 years 6.6 years Expected volatility 36.6 % 34.7 % Dividend yield 4.6 % 2.9 % The following table summarizes other information about the stock options at March 31, 2022: March 31, 2022 (amounts in thousands, except per share data) Outstanding: Aggregate intrinsic value $ 165 Weighted average remaining contractual life 5.4 years Exercisable: Number of options 1,697 Weighted average exercise price $ 34.51 Aggregate intrinsic value $ — Weighted average remaining contractual life 4.0 years Restricted Stock Units The fair value of outstanding restricted stock units was determined based on the market price of the shares on the date of grant. During the three months ended March 31, 2022, the Company granted 0.4 million restricted stock units to its employees with a weighted average grant date fair value of $18.10 per unit. During the three months ended March 31, 2021, the Company granted 0.3 million restricted stock units with a weighted average grant date fair value of $28.53 per unit. A summary of the outstanding restricted stock units as of December 31, 2021 and changes during the three months ended March 31, 2022 is as follows: Restricted Stock Units Number Weighted Average Grant Date Fair Value (in thousands) December 31, 2021 652 $ 31.03 Granted 391 $ 18.10 Vested (181) $ 33.59 Forfeited (19) $ 28.32 March 31, 2022 843 $ 24.55 Performance Stock Units On January 4, 2022, the NCSO granted 60,000 Performance Stock Units (“PSUs”) to the Company's executive officers. Such PSUs are contingent upon the achievement of certain total shareholder return (“TSR”) targets as compared to the TSR of the S&P 400 MidCap Index and the participant's continued employment with the Company for the three year period ending December 31, 2024, the date at which such PSUs vest. The unrecognized share-based compensation cost of the TSR-based PSU awards at March 31, 2022 is $1.9 million and is expected to be recognized over a weighted-average period of 2.5 years. A summary of the outstanding PSUs as of December 31, 2021 and changes during the three months ended March 31, 2022 is as follows: Performance Stock Units Number Weighted Average Grant Date Fair Value (in thousands) December 31, 2021 35 $ 34.52 Granted 60 $ 21.00 Vested — $ — Forfeited — $ — March 31, 2022 95 $ 26.01 Deferred Stock Units On January 4, 2022 , the NCSO granted 1,000 Deferred Stock Units ( “ DSUs ” ) to a non-employee member of the Board of Directors. This DSU award vests on June 4, 2022. Once vested, the recipient shall be entitled to receive a lump sum payment of a number of shares equal to the total number of DSUs issued to such recipient upon the first to occur of (i) the five year anniversary of the date of grant, (ii) the recipient's death, disability or separation of service from the Board, or (iii) a change of control (as defined by the 2020 Plan). The unrecognized share-based compensation cost of outstanding DSU awards at March 31, 2022 is $0.1 million and is expected to be recognized over a weighted-average period of 0.2 years. Employee Stock Purchase Plan The Company’s Employee Stock Purchase Plan (“ESPP”) is currently available through 2026 to all eligible employees. All full-time and part-time employees who work an average of 20 hours per week and have completed two years of continuous service with the Company are eligible to participate. Annual offerings commence and terminate on the respective year’s first and last calendar day. Under the ESPP, the Company is authorized to issue up to 4.1 million shares of its common stock to its employees. Pursuant to such authorization, there are 2.0 million shares available for future grant at March 31, 2022. The expense associated with the options granted under the ESPP during the three months ended March 31, 2022 and 2021 was estimated on the date of grant using the Black-Scholes option valuation model with the following assumptions: Three Months Ended March 31, 2022 2021 Risk-free interest rate 0.4% 0.1% Weighted average expected life (years) 1.0 1.0 Expected volatility 36.9% 61.7% Dividend yield 4.7% 2.9% Deferred Compensation Plan The Company offers a Supplemental Executive Retirement Plan (“SERP”) for executives and certain key employees. The SERP allows participants to defer a portion of their earned income on a pre-tax basis and as of the last day of each plan year, each participant will be credited with a match of a portion of their deferral in the form of the Company’s common stock based on the then-current market value. Under the SERP, the Company is authorized to issue 1.0 million shares of its common stock to its employees. Pursuant to such authorization, the Company has 0.3 million shares available for future grant at March 31, 2022. At the time of issuance, such shares are accounted for at cost as treasury stock. The following table summarizes information about the SERP during the three months ended March 31, 2022 and 2021: Three Months Ended March 31, 2022 2021 (in thousands) SERP expense 1 $ 157 $ 186 Unrealized (loss) gain recorded in SERP liability account $ (3,785) $ 1,301 1. Both the SERP match and the deferrals are included in the “ selling, general and administrative ”

Income Taxes

Income Taxes	3 Months Ended
	Mar. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Note 11—Income Taxes The Company’s annual effective tax rate is impacted by the tax effects of option exercises and the vesting of awards, which are treated as discrete items in the reporting period in which they occur, and therefore cannot be considered in the calculation of the estimated annual effective tax rate. The impact on the Company’s income tax provision through the three months ended March 31, 2022 for such discrete items was approximately $0.8 million. Differences between the effective tax rate and the applicable U.S. federal statutory rate arise primarily from the effect of state and local income taxes, share-based compensation and tax credits available to the Company. The actual 2022 effective tax rate will likely vary from the estimate depending on the actual operating income earned with availability of tax credits and the exercise of stock options and vesting of share-based awards.

Segment Information

Segment Information	3 Months Ended
	Mar. 31, 2022
Segment Reporting [Abstract]
Segment Information	Note 12—Segment Information The Company manages and evaluates its operations in two reportable segments: Housekeeping (housekeeping, laundry, linen and other services) and Dietary (dietary department services). Although both segments serve a similar customer base and share many operational similarities, they are managed separately due to distinct differences in the type of services provided, as well as the specialized expertise required of the professional management personnel responsible for delivering each segment’s services. Such services are rendered pursuant to discrete contracts, specific to each reportable segment. The Company’s accounting policies for the segments are generally the same as described in the Company’s significant accounting policies. Differences between the reportable segments’ operating results and other disclosed data and the information in the consolidated financial statements relate primarily to corporate level transactions and recording of transactions at the reportable segment level using other than generally accepted accounting principles. There are certain inventories and supplies that are primarily expensed when incurred within the operating segments, while they are capitalized in the consolidated financial statements. In addition, most corporate expenses such as corporate salary and benefit costs, certain legal costs, debt expense, information technology costs, depreciation, amortization of finite-lived intangible assets, share based compensation costs and other corporate-specific costs, are not fully allocated to the operating segments. There are also allocations for workers’ compensation and general liability expense within the operating segments that differ from the actual expense recorded by the Company under U.S. GAAP. Segment amounts disclosed are prior to elimination entries made in consolidation. Three Months Ended March 31, 2022 2021 (in thousands) Revenues Housekeeping $ 201,704 $ 215,058 Dietary 225,107 192,693 Total $ 426,811 $ 407,751 Income before income taxes Housekeeping $ 20,399 $ 28,167 Dietary 9,433 20,048 Corporate and eliminations 1 (14,051) (15,263) Total $ 15,781 $ 32,952 1. Primarily represents corporate office costs and related overhead, recording of certain inventories and supplies and workers compensation costs at the reportable segment level which use accounting methods that differ from those used at the corporate level, as well as consolidated subsidiaries’ operating expenses that are not allocated to the reportable segments, net of investment and other income and interest expense.

Earnings Per Common Share

Earnings Per Common Share	3 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
Earnings Per Common Share	Note 13—Earnings Per Common Share Basic and diluted earnings per common share are computed by dividing net income by the weighted-average number of basic and diluted common shares outstanding, respectively. The weighted-average number of diluted common shares includes the impact of dilutive securities, including outstanding stock options, restricted stock units, and performance stock units. The table below reconciles the weighted-average basic and diluted common shares outstanding: Three Months Ended March 31, 2022 2021 (in thousands) Numerator for basic and diluted earnings per share: Net income $ 11,329 $ 24,653 Denominator Weighted average number of common shares outstanding - basic 74,326 75,003 Effect of dilutive securities 1 7 221 Weighted average number of common shares outstanding - diluted 74,333 75,224 Basic earnings per share: $ 0.15 $ 0.33 Diluted earnings per share: $ 0.15 $ 0.33 1. Certain outstanding equity awards are anti-dilutive and therefore excluded from the calculation of the weighted average number of diluted common shares outstanding. Anti-dilutive outstanding equity awards under share-based compensation plans were as follows: Three Months Ended March 31, 2022 2021 (in thousands) Anti-dilutive 3,369 1,694

Other Contingencies

Other Contingencies	3 Months Ended
	Mar. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Other Contingencies	Note 14—Other Contingencies Line of Credit At March 31, 2022, the Company had a $475 million bank line of credit on which to draw for general corporate purposes. Amounts drawn under the line of credit are payable upon demand and generally bear interest at a floating rate, based on the Company’s leverage ratio, and starting at LIBOR plus 115 basis points (or if LIBOR becomes unavailable, the higher of the Overnight Bank Funding Rate, plus 50 basis points and the Prime Rate). As of March 31, 2022, there were $10 million in borrowings under the line of credit. As of December 31, 2021, there were no borrowings under the line of credit. The line of credit requires the Company to satisfy two financial covenants, with which the Company is in compliance as of March 31, 2022. The line of credit expires on December 21, 2023. At March 31, 2022, the Company also had outstanding $81.0 million in irrevocable standby letters of credit, which relate to payment obligations under the Company’s insurance programs. In connection with the issuance of the letters of credit, the amount available under the line of credit was reduced by $81.0 million to $384.0 million at March 31, 2022. The letters of credit expire on January 4, 2023. Tax Jurisdictions and Matters The Company provides services throughout the continental United States and is subject to numerous state and local taxing jurisdictions. In the ordinary course of business, a jurisdiction may contest the Company’s reporting positions with respect to the application of its tax code to the Company’s services, which could result in additional tax liabilities. The Company has tax matters with various taxing authorities. Because of the uncertainties related to both the probable outcomes and amount of probable assessments due, the Company is unable to make a reasonable estimate of a liability. The Company does not expect the resolution of any of these matters, taken individually or in the aggregate, to have a material adverse effect on the consolidated financial position or results of operations based on the Company’s best estimate of the outcomes of such matters. Legal Proceedings The Company is subject to various claims and legal actions in the ordinary course of business. Some of these matters include payroll and employee-related matters and examinations by governmental agencies. As the Company becomes aware of such claims and legal actions, the Company records accruals for any exposures that are probable and estimable. If adverse outcomes of such claims and legal actions are reasonably possible, Management assesses materiality and provides financial disclosure, as appropriate. At this time, the Company is unable to reasonably estimate possible losses or form a judgment that an unfavorable outcome is either probable or remote with respect to certain pending litigation claims asserted and it is not currently possible to assess whether or not the outcome of these proceedings may have a material adverse effect on the Company. Government Regulations

Subsequent Events

Subsequent Events	3 Months Ended
	Mar. 31, 2022
Subsequent Events [Abstract]
Subsequent Events	Note 15—Subsequent Events The Company evaluated all subsequent events through the filing date of this Form 10-Q. There were no events or transactions occurring during this subsequent reporting period which require recognition or additional disclosure in these financial statements.

Description of Business and S_2

Description of Business and Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2022
Accounting Policies [Abstract]
Nature of Operations	Healthcare Services Group, Inc. (the “Company”) provides management, administrative and operating expertise and services to the housekeeping, laundry, linen, facility maintenance and dietary service departments of the healthcare industry, including nursing homes, retirement complexes, rehabilitation centers and hospitals located throughout the United States. Although the Company does not directly participate in any government reimbursement programs, the Company’s customers receive government reimbursements related to Medicare and Medicaid. Therefore, they are directly affected by any legislation relating to Medicare and Medicaid reimbursement programs. The Company provides services primarily pursuant to full service agreements with its customers. In such agreements, the Company is responsible for the day-to-day management of employees located at the customers’ facilities, as well as for the provision of certain supplies. The Company also provides services on the basis of management-only agreements for a limited number of customers. In a management-only agreement, the Company provides management and supervisory services while the customer facility retains payroll responsibility for the non-supervisory staff. The agreements with customers typically provide for a renewable one year service term, cancellable by either party upon 30 to 90 days’ notice after an initial period of 60 to 120 days. The Company is organized into two reportable segments: housekeeping, laundry, linen and other services (“Housekeeping”), and dietary department services (“Dietary”). Housekeeping consists of managing the customers’ housekeeping departments, which are principally responsible for the cleaning, disinfecting and sanitizing of resident rooms and common areas of a customer’s facility, as well as the laundering and processing of the bed linens, uniforms, resident personal clothing and other assorted linen items utilized at a customer facility. Dietary consists of managing the customers’ dietary departments, which are principally responsible for food purchasing, meal preparation and dietitian professional services, which includes the development of menus that meet residents’ dietary needs.
Unaudited Interim Financial Data	The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States (“U.S. GAAP”) for interim financial information and the requirements of Form 10-Q and Article 10 of Regulation S-X. Accordingly, these consolidated financial statements do not include all of the information and footnotes necessary for a complete presentation of financial position, results of operations and cash flows. However, in the Company’s opinion, all adjustments which are of a normal recurring nature and are necessary for a fair presentation have been reflected in these consolidated financial statements. The balance sheet shown in this report as of December 31, 2021 has been derived from the audited financial statements for the year ended December 31, 2021. These financial statements should be read in conjunction with the financial statements and notes thereto included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2021. The results of operations for the three months ended March 31, 2022 are not necessarily indicative of the results that may be expected for any future period.
Use of Estimates in Financial Statements	In preparing financial statements in conformity with U.S. GAAP, estimates and assumptions are made that affect the reported amounts of assets and liabilities, disclosures of contingent assets and liabilities, and the reported amounts of revenues and expenses. Actual results could differ from those estimates. Significant estimates are used in determining, but are not limited to, the Company’s allowance for doubtful accounts, accrued insurance claims, valuations, deferred taxes and reviews for potential impairment. The estimates are based upon various factors including current and historical trends, as well as other pertinent industry and regulatory authority information, including the potential future effects of COVID-19. Management regularly evaluates this information to determine if it is necessary to update the basis for its estimates and to adjust for known changes.
Principles of Consolidation	The accompanying consolidated financial statements include the accounts of Healthcare Services Group, Inc. and its wholly-owned subsidiaries. All significant intercompany transactions and balances have been eliminated in consolidation.
Cash and Cash Equivalents	Cash and cash equivalents are held in U.S. financial institutions or in custodial accounts with U.S. financial institutions. Cash equivalents are defined as short-term, highly liquid investments with a maturity of three months or less at time of purchase that are readily convertible into cash and have insignificant interest rate risk.
Accounts and Notes Receivable	Accounts and notes receivable consist of Housekeeping and Dietary segment trade receivables from contracts with customers. The Company’s payment terms with customers for services provided are defined within each customer’s service agreement. All accounts receivables are considered short term assets as the Company does not grant payment terms greater than one year. Accounts receivable initially are recorded at the transaction amount, and are recorded after the Company has an unconditional right to payment where only the passage of time is required before payment is received. Each reporting period, the Company evaluates the collectability of outstanding receivable balances and records an allowance for doubtful accounts representing an estimate of future expected credit loss. Additions to the allowance for doubtful accounts are made by recording a charge to bad debt expense reported in costs of services provided. Notes receivable are initially recorded when accounts receivable are transferred into a promissory note and are recorded as an alternative to accounts receivable to memorialize an unqualified promise to pay a specific sum, typically with interest, in accordance with a defined payment schedule. The Company’s payment terms with customers on promissory notes can vary based on several factors and the circumstances of each promissory note, however typically promissory notes mature over a 1 to 3 year period. Similar to accounts receivable, each reporting period the Company evaluates the collectability of outstanding notes receivable balances and records an allowance for doubtful accounts representing an estimate of future expected credit loss.
Allowance for Doubtful Accounts	Allowance for Doubtful Accounts In accordance with Financial Accounting Standards Board (“FASB”) Accounting Standards Codification subtopic 326 Credit Losses - Measurement of Credit Losses on Financial Instruments (“ASC 326”), Management utilizes financial modeling to determine an allowance that reflects its best estimate of the lifetime expected credit losses on accounts and notes receivable which is recorded as a liability to offset the receivables. Modeling is prepared after considering historical experience, current conditions, and reasonable and supportable economic forecasts to estimate lifetime expected credit losses. Accounts and notes receivables are written off when deemed uncollectible. Recoveries of receivables previously written off are recorded as a reduction of bad debt expense when received.
Inventories and Supplies	Inventories and supplies include housekeeping, linen and laundry supplies, as well as food provisions and supplies. Non-linen inventories and supplies are stated on a first-in, first-out (FIFO) basis, and reduced as deemed necessary to approximate the lower of cost or net realizable value. Linen supplies are amortized on a straight-line basis over their estimated useful life of 24 months.
Revenue Recognition	The Company recognizes revenue from contracts with customers when or as the promised goods and services are provided to customers. Revenues are reported net of sales taxes that are collected from customers and remitted to taxing authorities. The amount of revenue recognized by the Company is based on the consideration to which the Company is entitled in exchange for providing the contracted goods and services.
Leases	The Company records assets and liabilities on the balance sheet to recognize the rights and obligations arising from leasing arrangements with contractual terms greater than 12 months, in accordance with FASB Accounting Standards Codification subtopic ASC 842 Leases (“ASC 842”). A leasing arrangement includes any contract which entitles the Company to the right of use of an identified tangible asset where there are no restrictions as to the direct of use of the asset, and the Company obtains substantially all of the economic benefits from the right of use. As of March 31, 2022 and December 31, 2021, the Company was only the lessee of operating lease arrangements.
Income Taxes	The Company uses the asset and liability method of accounting for income taxes. Under this method, income tax expense or benefits are recognized for the amount of taxes payable or refundable for the current period. The Company accrues for probable tax obligations as required, based on facts and circumstances in various regulatory environments. In addition, deferred tax assets and liabilities are recognized for the expected future tax consequences of temporary differences between the financial reporting and tax bases of assets and liabilities. When appropriate, valuation allowances are recorded to reduce deferred tax assets to amounts for which realization is more likely than not. Uncertain income tax positions taken or expected to be taken in tax returns are reflected within the Company’s financial statements based on a recognition and measurement process.
Earnings per Common Share	Basic earnings per common share is computed by dividing income available to common shareholders by the weighted-average number of common shares outstanding for the period. Diluted earnings per common share is computed using the weighted-average number of common shares outstanding and dilutive common shares, such as those issuable upon exercise of stock options and upon the vesting of restricted stock units.
Share-Based Compensation	The Company estimates the fair value of share-based awards on the date of grant using the Black-Scholes valuation model for stock options, using a Monte Carlo simulation for performance restricted stock units, and using the share price on the date of grant for restricted stock units and deferred stock units. The value of the award is recognized ratably as an expense in the Company’s Consolidated Statements of Comprehensive Income over the requisite service periods, with adjustments made for forfeitures as they occur.
Identifiable Intangible Assets and Goodwill	Identifiable intangible assets are amortized on a straight-line basis over their respective lives. Goodwill represents the excess of cost over the fair value of net assets of acquired businesses. Management reviews the carrying value of goodwill annually during the fourth quarter to assess for impairment, or more often if events or circumstances indicate that the carrying value may exceed its estimated fair value.
Concentrations of Credit Risk	The Company’s financial instruments that are subject to credit risk are cash and cash equivalents, marketable securities, deferred compensation funding and accounts and notes receivable. At March 31, 2022 and December 31, 2021, substantially all of the Company’s cash and cash equivalents and marketable securities were held in one large financial institution located in the United States. The Company’s marketable securities are fixed income investments which are highly liquid and can be readily purchased or sold through established markets. The Company’s customers are concentrated in the healthcare industry and are primarily providers of long-term care. The revenues of many of the Company’s customers are highly reliant on Medicare, Medicaid and third party payors’ reimbursement funding rates. New legislation or changes in existing regulations could directly impact the governmental reimbursement programs in which the customers participate. As a result, the Company may not realize the full effects of such programs until these laws are fully implemented and governmental agencies issue applicable regulations or guidance.
Segments	The Company’s accounting policies for the segments are generally the same as described in the Company’s significant accounting policies. Differences between the reportable segments’ operating results and other disclosed data and the information in the consolidated financial statements relate primarily to corporate level transactions and recording of transactions at the reportable segment level using other than generally accepted accounting principles. There are certain inventories and supplies that are primarily expensed when incurred within the operating segments, while they are capitalized in the consolidated financial statements. In addition, most corporate expenses such as corporate salary and benefit costs, certain legal costs, debt expense, information technology costs, depreciation, amortization of finite-lived intangible assets, share based compensation costs and other corporate-specific costs, are not fully allocated to the operating segments. There are also allocations for workers’ compensation and general liability expense within the operating segments that differ from the actual expense recorded by the Company under U.S. GAAP. Segment amounts disclosed are prior to elimination entries made in consolidation.

Accounts and Notes Receivable (

Accounts and Notes Receivable (Tables)	3 Months Ended
	Mar. 31, 2022
Receivables [Abstract]
Schedule of Accounts and Notes Receivable	The Company’s accounts and notes receivable balances consisted of the following as of March 31, 2022 and December 31, 2021: March 31, 2022 December 31, 2021 (in thousands) Short-term Accounts and notes receivable $ 376,879 $ 352,659 Allowance for doubtful accounts (57,784) (59,271) Total net short-term accounts and notes receivable $ 319,095 $ 293,388 Long-term Notes receivable $ 33,231 $ 35,571 Allowance for doubtful accounts (5,308) (6,312) Total net long-term notes receivable $ 27,923 $ 29,259 Total net accounts and notes receivable $ 347,018 $ 322,647

Allowance for Doubtful Accoun_2

Allowance for Doubtful Accounts (Tables)	3 Months Ended
	Mar. 31, 2022
Receivables [Abstract]
Notes Receivable Disaggregated by Vintage Year	The following table presents the Company’s two tiers of notes receivable further disaggregated by year of origination, as well as write-off activity for the three months ended March 31, 2022. Notes Receivable Amortized Cost Basis by Origination Year 2022 2021 2020 2019 2018 Prior Total (in thousands) Notes Receivable Standard notes receivable $ 486 $ 15,461 $ 5,588 $ 272 $ 18,715 $ 22,842 $ 63,364 Elevated risk notes receivable $ — $ — $ — $ — $ — $ 1,715 $ 1,715 Current-period gross write-offs $ — $ — $ — $ — $ — $ — $ — Current-period recoveries — — — — — — — Current-period net write-offs $ — $ — $ — $ — $ — $ — $ —
Age Analysis of Past-Due Note Receivable	The following table provides information as to the status of payment on the Company’s notes receivable which were past due as of March 31, 2022: Age Analysis of Past-Due Notes Receivable as of March 31, 2022 0 - 90 Days 91 - 180 Days Greater than 181 Days Total (in thousands) Notes Receivable Standard notes receivable $ 1,030 $ 608 $ 12,176 $ 13,814 Elevated risk notes receivable — — 1,715 1,715 $ 1,030 $ 608 $ 13,891 $ 15,529
Schedule of Changes in Allowance for Doubtful Accounts	The following tables provide a summary of the changes in the Company’s allowance for doubtful accounts on a portfolio segment basis for the three months ended March 31, 2022 and 2021. Allowance for doubtful accounts Portfolio Segment: December 31, Write-Offs 1 Bad Debt Expense March 31, (in thousands) Accounts Receivables $ 50,794 $ (5,343) $ 3,960 $ 49,411 Notes Receivables Standard notes receivable $ 13,607 $ — $ (1,065) $ 12,542 Elevated risk notes receivable 1,183 — (44) 1,139 Total notes receivable $ 14,790 $ — $ (1,109) $ 13,681 Total accounts and notes receivable $ 65,584 $ (5,343) $ 2,851 $ 63,092 1. Write-offs are shown net of recoveries. During the three months ended March 31, 2022, the Company collected $0.2 million of accounts receivables and notes receivables which had previously been written-off as uncollectible. Allowance for doubtful accounts Portfolio Segment: December 31, Write-Offs 1 Bad Debt Expense March 31, (in thousands) Accounts Receivables $ 51,052 $ (7,305) $ 2,779 $ 46,526 Notes Receivables Standard notes receivable $ 13,258 $ (9) $ (256) $ 12,993 Elevated risk notes receivable 3,491 (2,800) 892 1,583 Total notes receivable $ 16,749 $ (2,809) $ 636 $ 14,576 Total Accounts and notes receivable $ 67,801 $ (10,114) $ 3,415 $ 61,102 1. Write-offs are shown net of recoveries. During the three months ended March 31, 2021, the amount of such recoveries was not material.
Schedule of Changes in Allowance for Notes Receivable	The following tables provide a summary of the changes in the Company’s allowance for doubtful accounts on a portfolio segment basis for the three months ended March 31, 2022 and 2021. Allowance for doubtful accounts Portfolio Segment: December 31, Write-Offs 1 Bad Debt Expense March 31, (in thousands) Accounts Receivables $ 50,794 $ (5,343) $ 3,960 $ 49,411 Notes Receivables Standard notes receivable $ 13,607 $ — $ (1,065) $ 12,542 Elevated risk notes receivable 1,183 — (44) 1,139 Total notes receivable $ 14,790 $ — $ (1,109) $ 13,681 Total accounts and notes receivable $ 65,584 $ (5,343) $ 2,851 $ 63,092 1. Write-offs are shown net of recoveries. During the three months ended March 31, 2022, the Company collected $0.2 million of accounts receivables and notes receivables which had previously been written-off as uncollectible. Allowance for doubtful accounts Portfolio Segment: December 31, Write-Offs 1 Bad Debt Expense March 31, (in thousands) Accounts Receivables $ 51,052 $ (7,305) $ 2,779 $ 46,526 Notes Receivables Standard notes receivable $ 13,258 $ (9) $ (256) $ 12,993 Elevated risk notes receivable 3,491 (2,800) 892 1,583 Total notes receivable $ 16,749 $ (2,809) $ 636 $ 14,576 Total Accounts and notes receivable $ 67,801 $ (10,114) $ 3,415 $ 61,102 1. Write-offs are shown net of recoveries. During the three months ended March 31, 2021, the amount of such recoveries was not material.

Changes in Accumulated Other _2

Changes in Accumulated Other Comprehensive Income by Component (Tables)	3 Months Ended
	Mar. 31, 2022
Equity [Abstract]
Schedule of Accumulated Other Comprehensive Income	The following table provides a summary of the changes in accumulated other comprehensive income for the three months ended March 31, 2022 and 2021: Unrealized Gains and Losses on Available-for-Sale Securities 1 Three Months Ended March 31, 2022 2021 (in thousands) Accumulated other comprehensive income — beginning balance $ 4,000 $ 5,563 Other comprehensive loss before reclassifications (5,277) (1,307) Losses reclassified from other comprehensive income 2 8 36 Net current period other comprehensive loss 3 (5,269) (1,271) Accumulated other comprehensive (loss) income — ending balance $ (1,269) $ 4,292 1. All amounts are net of tax 2. Realized gains and losses were recorded pre-tax under “Investment and other income” in the Consolidated Statements of Comprehensive Income. For the three months ended March 31, 2022 and 2021, the Company recorded less than $0.1 million of realized losses from the sale of available-for-sale securities. Refer to Note 9—Fair Value Measurements herein for further information. 3. For the three months ended March 31, 2022 and 2021, the changes in other comprehensive income were net of a tax benefit of $1.4 million and $0.3 million, respectively.
Schedule of Reclassification out of Accumulated Other Comprehensive Income	Amounts Reclassified from Accumulated Other Comprehensive Income 2022 2021 (in thousands) Three Months Ended March 31, Losses from the sale of available-for-sale securities $ (12) $ (48) Tax benefit 4 12 Net loss reclassified from accumulated other comprehensive income $ (8) $ (36)

Property and Equipment (Tables)

Property and Equipment (Tables)	3 Months Ended
	Mar. 31, 2022
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment	The following table sets forth the amounts of property and equipment by each class of depreciable asset as of March 31, 2022 and December 31, 2021: March 31, 2022 December 31, 2021 (in thousands) Housekeeping and dietary equipment $ 13,614 $ 13,468 Computer hardware and software 5,976 5,880 Operating lease — right-of-use assets 33,446 33,217 Other 1 1,680 1,736 Total property and equipment, at cost 54,716 54,301 Less accumulated depreciation 28,014 26,199 Total property and equipment, net $ 26,702 $ 28,102 1. Includes furniture and fixtures, leasehold improvements and autos and trucks including auto leases.

Leases (Tables)

Leases (Tables)	3 Months Ended
	Mar. 31, 2022
Leases [Abstract]
Schedule of Components of Lease Expense	Components of lease expense required by ASC 842 are presented below for the three months ended March 31, 2022 and 2021. Three Months Ended March 31, 2022 2021 (in thousands) Lease cost Operating lease cost $ 1,386 $ 1,439 Short-term lease cost 355 167 Variable lease cost 82 72 Total lease cost $ 1,823 $ 1,678
Schedule of Supplemental Information Required by ASC 842	Supplemental information required by ASC 842 is presented below for the three months ended March 31, 2022 and 2021. Three Months Ended March 31, 2022 2021 (dollar amounts in thousands) Other information Cash paid for amounts included in the measurement of lease liabilities Operating cash flows from operating leases $ 1,711 $ 1,583 Weighted-average remaining lease term — operating leases 4.4 years 5.6 years Weighted-average discount rate — operating leases 4.2 % 4.2 %
Schedule of Future Minimum Lease Payments	The following is a schedule by calendar year of future minimum lease payments under operating leases that have remaining terms as of March 31, 2022: Period/Year Operating Leases (in thousands) April 1 to December 31, 2022 $ 4,634 2023 4,956 2024 3,119 2025 1,396 2026 1,337 2027 1,363 Thereafter 1,505 Total minimum lease payments $ 18,310 Less: imputed lease payments 1,703 Present value of lease liabilities $ 16,607

Goodwill and Other Intangible_2

Goodwill and Other Intangible Assets (Tables)	3 Months Ended
	Mar. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Estimated Amortization Expense For Intangibles Subject To Amortization	The following table sets forth the estimated amortization expense for intangibles subject to amortization for the remainder of 2022, the following five fiscal years and thereafter: Period/Year Total Amortization Expense (in thousands) April 1 to December 31, 2022 $ 3,642 2023 $ 3,819 2024 $ 2,685 2025 $ 2,685 2026 $ 2,665 2027 $ 1,196 Thereafter $ 2,895

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	3 Months Ended
	Mar. 31, 2022
Fair Value Disclosures [Abstract]
Schedule of Fair Value Measurements	The following tables provide fair value measurement information for the Company’s marketable securities and deferred compensation fund investments as of March 31, 2022 and December 31, 2021: As of March 31, 2022 Fair Value Measurement Using: Carrying Amount Total Fair Value Quoted Prices in Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Financial Assets: Marketable securities Municipal bonds — available-for-sale $ 107,171 $ 107,171 $ — $ 107,171 $ — Deferred compensation fund Money Market 1 $ 2,428 $ 2,428 $ — $ 2,428 $ — Balanced and Lifestyle 12,194 12,194 12,194 — — Large Cap Growth 16,206 16,206 16,206 — — Small Cap Growth 5,174 5,174 5,174 — — Fixed Income 4,414 4,414 4,414 — — International 1,719 1,719 1,719 — — Mid Cap Growth 3,171 3,171 3,171 — — Deferred compensation fund 2 $ 45,306 $ 45,306 $ 42,878 $ 2,428 $ — As of December 31, 2021 Fair Value Measurement Using: Carrying Total Fair Quoted Prices in Active Markets (Level 1) Significant Other Observable Inputs (Level 2) Significant Unobservable Inputs (Level 3) Financial Assets: Marketable securities Municipal bonds — available-for-sale $ 114,396 $ 114,396 $ — $ 114,396 $ — Deferred compensation fund Money Market 1 $ 2,882 $ 2,882 $ — $ 2,882 $ — Balanced and Lifestyle 12,578 12,578 12,578 — — Large Cap Growth 20,358 20,358 20,358 — — Small Cap Growth 6,561 6,561 6,561 — — Fixed Income 4,826 4,826 4,826 — — International 2,299 2,299 2,299 — Mid Cap Growth 4,179 4,179 4,179 — — Deferred compensation fund 2 $ 53,683 $ 53,683 $ 50,801 $ 2,882 $ — 1. The fair value of the money market fund is based on the net asset value (“NAV”) of the shares held by the plan at the end of the period. The money market fund includes short-term United States dollar denominated money market instruments and the NAV is determined by the custodian of the fund. The money market fund can be redeemed at its NAV at the measurement date as there are no significant restrictions on the ability to sell this investment.
Schedule of Marketable Debt Securities	Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Estimated Fair Value Credit Impairment Losses 1 (in thousands) March 31, 2022 Type of security: Municipal bonds — available-for-sale $ 108,778 $ 1,141 $ (2,748) $ 107,171 $ — Total debt securities $ 108,778 $ 1,141 $ (2,748) $ 107,171 $ — December 31, 2021 Type of security: Municipal bonds — available-for-sale $ 109,331 $ 5,219 $ (154) $ 114,396 $ — Total debt securities $ 109,331 $ 5,219 $ (154) $ 114,396 $ — 1. The Company performs a quarterly credit impairment loss assessment quarterly on an individual security basis. As of March 31, 2022 and December 31, 2021, no allowance for credit loss impairment has been recognized as the issuers of these securities have not established a cause for default and various rating agencies have reaffirmed each security's investment grade status. The fair value of these securities have fluctuated since the purchase date as market interest rates fluctuate. The Company does not intend to sell these securities and it is more likely than not that the Company will not be required to sell before the recovery of the securities' amortized cost basis.
Schedule of Contractual Maturities of Available for Sale Investments	The following table summarizes the contractual maturities of debt securities held at March 31, 2022 and December 31, 2021, which are classified as “Marketable securities, at fair value” in the Consolidated Balance Sheets: Municipal Bonds — Available-for-Sale Contractual maturity: March 31, 2022 December 31, 2021 (in thousands) Maturing in one year or less $ 4,290 $ 5,606 Maturing in second year through fifth year 28,031 23,054 Maturing in sixth year through tenth year 44,174 52,180 Maturing after ten years 30,676 33,556 Total debt securities $ 107,171 $ 114,396

Share-Based Compensation (Table

Share-Based Compensation (Tables)	3 Months Ended
	Mar. 31, 2022
Share-based Payment Arrangement [Abstract]
Schedule of Stock-based Compensation Expense	The components of the Company’s shared-based compensation expense for the three months ended March 31, 2022 and 2021 are as follows: Three Months Ended March 31, 2022 2021 (in thousands) Stock options $ 314 $ 458 Restricted stock and restricted stock units 1,785 1,550 Performance stock units 199 96 Employee Stock Purchase Plan 98 167 Total pre-tax share-based compensation expense charged against income 1 $ 2,396 $ 2,271 1. Share-based compensation expense is recorded in “C osts of services provided ” and “S elling, general and administrative expense ”
Schedule of Other Information of Stock Option Plans	A summary of stock options outstanding under the 2020 Plan and the 2012 Plan as of December 31, 2021 and changes during the three months ended March 31, 2022 are as follows: Stock Options Outstanding Number of Shares Weighted Average Exercise Price (in thousands) December 31, 2021 2,181 $ 33.42 Granted 352 $ 18.10 Exercised (23) $ 17.50 Forfeited — $ — Expired (56) $ 21.68 March 31, 2022 2,454 $ 31.64
Schedule of Assumption For Fair Value of Options Granted	The fair value of stock option awards granted in 2022 and 2021 was estimated on the date of grant using the Black-Scholes option valuation model with the following assumptions: Three Months Ended March 31, 2022 2021 Risk-free interest rate 1.5 % 0.6 % Weighted average expected life 6.7 years 6.6 years Expected volatility 36.6 % 34.7 % Dividend yield 4.6 % 2.9 %
Schedule of Summarized Information of Stock Options Outstanding	The following table summarizes other information about the stock options at March 31, 2022: March 31, 2022 (amounts in thousands, except per share data) Outstanding: Aggregate intrinsic value $ 165 Weighted average remaining contractual life 5.4 years Exercisable: Number of options 1,697 Weighted average exercise price $ 34.51 Aggregate intrinsic value $ — Weighted average remaining contractual life 4.0 years
Schedule of Outstanding Restricted Stock Units	A summary of the outstanding restricted stock units as of December 31, 2021 and changes during the three months ended March 31, 2022 is as follows: Restricted Stock Units Number Weighted Average Grant Date Fair Value (in thousands) December 31, 2021 652 $ 31.03 Granted 391 $ 18.10 Vested (181) $ 33.59 Forfeited (19) $ 28.32 March 31, 2022 843 $ 24.55
Schedule of Outstanding Performance Stock Units	A summary of the outstanding PSUs as of December 31, 2021 and changes during the three months ended March 31, 2022 is as follows: Performance Stock Units Number Weighted Average Grant Date Fair Value (in thousands) December 31, 2021 35 $ 34.52 Granted 60 $ 21.00 Vested — $ — Forfeited — $ — March 31, 2022 95 $ 26.01
Schedule of Options Granted Estimated Expense Valuation Assumptions	The expense associated with the options granted under the ESPP during the three months ended March 31, 2022 and 2021 was estimated on the date of grant using the Black-Scholes option valuation model with the following assumptions: Three Months Ended March 31, 2022 2021 Risk-free interest rate 0.4% 0.1% Weighted average expected life (years) 1.0 1.0 Expected volatility 36.9% 61.7% Dividend yield 4.7% 2.9%
Schedule of ESPP Annual Offerings	The following table summarizes information about the SERP during the three months ended March 31, 2022 and 2021: Three Months Ended March 31, 2022 2021 (in thousands) SERP expense 1 $ 157 $ 186 Unrealized (loss) gain recorded in SERP liability account $ (3,785) $ 1,301 1. Both the SERP match and the deferrals are included in the “ selling, general and administrative ”

Segment Information (Tables)

Segment Information (Tables)	3 Months Ended
	Mar. 31, 2022
Segment Reporting [Abstract]
Schedule of Information of Reportable Segments	Three Months Ended March 31, 2022 2021 (in thousands) Revenues Housekeeping $ 201,704 $ 215,058 Dietary 225,107 192,693 Total $ 426,811 $ 407,751 Income before income taxes Housekeeping $ 20,399 $ 28,167 Dietary 9,433 20,048 Corporate and eliminations 1 (14,051) (15,263) Total $ 15,781 $ 32,952 1. Primarily represents corporate office costs and related overhead, recording of certain inventories and supplies and workers compensation costs at the reportable segment level which use accounting methods that differ from those used at the corporate level, as well as consolidated subsidiaries’ operating expenses that are not allocated to the reportable segments, net of investment and other income and interest expense.

Earnings Per Common Share (Tabl

Earnings Per Common Share (Tables)	3 Months Ended
	Mar. 31, 2022
Earnings Per Share [Abstract]
Schedule of Weighted Average Number of Shares	The table below reconciles the weighted-average basic and diluted common shares outstanding: Three Months Ended March 31, 2022 2021 (in thousands) Numerator for basic and diluted earnings per share: Net income $ 11,329 $ 24,653 Denominator Weighted average number of common shares outstanding - basic 74,326 75,003 Effect of dilutive securities 1 7 221 Weighted average number of common shares outstanding - diluted 74,333 75,224 Basic earnings per share: $ 0.15 $ 0.33 Diluted earnings per share: $ 0.15 $ 0.33
Schedule Anti-dilutive Outstanding Equity Awards Under Share Based Compensation Plans	Anti-dilutive outstanding equity awards under share-based compensation plans were as follows: Three Months Ended March 31, 2022 2021 (in thousands) Anti-dilutive 3,369 1,694

Description of Business and S_3

Description of Business and Significant Accounting Policies (Details)	3 Months Ended
	Mar. 31, 2022USD ($)segmentfinancial_institution	Mar. 31, 2021USD ($)	Dec. 31, 2021financial_institution
Schedule of Accounting Policies [Line Items]
Renewal term	1 year
Number of reportable segments | segment	2
Amortization period of inventories and supplies	24 months
Goodwill and intangible asset impairment | $	$ 0	$ 0
Number of financial institutions holding cash and cash equivalents and marketable securities | financial_institution	1		1
Minimum
Schedule of Accounting Policies [Line Items]
Cancellation notice period	30 days
Initial period preceding cancellation notice	60 days
Typically promissory notes maturity	1 year
Maximum
Schedule of Accounting Policies [Line Items]
Cancellation notice period	90 days
Initial period preceding cancellation notice	120 days
Typically promissory notes maturity	3 years

Revenue - Additional Informatio

Revenue - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Disaggregation of Revenue [Line Items]
Revenue	$ 426,811	$ 407,751
Renewal term	1 year
Description of timing	The Company’s contracts with customers typically provide for an initial term of one year, with renewable one year service terms, cancellable by either party upon 30 to 90 days’ notice after an initial period of 60 to 120 days.At March 31, 2022, the Company had $187.0 million related to performance obligations that were unsatisfied or partially unsatisfied for which the Company expects to recognize revenue. The Company expects to recognize revenue on approximately 52.2% of the remaining performance obligations over the next 12 months, with the balance to be recognized thereafter. These amounts exclude variable consideration primarily related to performance obligations that consist of a series of distinct service periods with revenues based on future performance that cannot be estimated at contract inception. The Company also has elected to apply the practical expedient that permits exclusion of information about the remaining performance obligations with original expected durations of one year or less.
Transferred at point in time
Disaggregation of Revenue [Line Items]
Contract liabilities	$ 800		$ 100
Transferred over time
Disaggregation of Revenue [Line Items]
Contract liabilities	$ 100		$ 2,500
Minimum
Disaggregation of Revenue [Line Items]
Cancellation notice period	30 days
Initial period preceding cancellation notice	60 days
Maximum
Disaggregation of Revenue [Line Items]
Cancellation notice period	90 days
Initial period preceding cancellation notice	120 days
Housekeeping
Disaggregation of Revenue [Line Items]
Revenue	$ 201,704	$ 215,058
Percent of revenue (as a percent)	47.30%	52.70%
Dietary
Disaggregation of Revenue [Line Items]
Revenue	$ 225,107	$ 192,693
Percent of revenue (as a percent)	52.70%	47.30%

Revenue - Transaction Price All

Revenue - Transaction Price Allocated to Remaining Performance Obligations (Details) $ in Millions	Mar. 31, 2022USD ($)
Revenue from Contract with Customer [Abstract]
Remaining performance obligation	$ 187
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-04-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation percent (as a percent)	52.20%
Revenue, remaining performance obligation period	12 months

Accounts and Notes Receivable -

Accounts and Notes Receivable - Schedule of Accounts and Notes Receivable (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Short-term
Accounts and notes receivable	$ 376,879	$ 352,659
Allowance for doubtful accounts	(57,784)	(59,271)
Total net short-term accounts and notes receivable	319,095	293,388
Long-term
Notes receivable	33,231	35,571
Allowance for doubtful accounts	(5,308)	(6,312)
Total net long-term notes receivable	27,923	29,259
Total net accounts and notes receivable	$ 347,018	$ 322,647

Allowance for Doubtful Accoun_3

Allowance for Doubtful Accounts - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Receivables [Abstract]
Interest income	$ 0.3	$ 0.4

Allowance for Doubtful Accoun_4

Allowance for Doubtful Accounts - Notes Receivable Disaggregated by Vintage Year (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Current-period gross write-offs
2022	$ 0
2021	0
2020	0
2019	0
2018	0
Prior	0
Total	0
Current-period recoveries
2022	0
2021	0
2020	0
2019	0
2018	0
Prior	0
Total	0
Current-period net write-offs
2022	0
2021	0
2020	0
2019	0
2018	0
Prior	0
Total	0	$ 2,809
Standard notes receivable
Financing Receivable, Credit Quality Indicator [Line Items]
2022	486
2021	15,461
2020	5,588
2019	272
2018	18,715
Prior	22,842
Total	63,364
Current-period net write-offs
Total	0	9
Elevated risk notes receivable
Financing Receivable, Credit Quality Indicator [Line Items]
2022	0
2021	0
2020	0
2019	0
2018	0
Prior	1,715
Total	1,715
Current-period net write-offs
Total	$ 0	$ 2,800

Allowance for Doubtful Accoun_5

Allowance for Doubtful Accounts - Age Analysis of Past-Due Note Receivable (Details) $ in Thousands	Mar. 31, 2022USD ($)
Total
Financing Receivable, Past Due [Line Items]
Notes Receivable	$ 15,529
0 - 90 Days
Financing Receivable, Past Due [Line Items]
Notes Receivable	1,030
91 - 180 Days
Financing Receivable, Past Due [Line Items]
Notes Receivable	608
Greater than 181 Days
Financing Receivable, Past Due [Line Items]
Notes Receivable	13,891
Standard notes receivable
Financing Receivable, Past Due [Line Items]
Notes Receivable	63,364
Standard notes receivable | Total
Financing Receivable, Past Due [Line Items]
Notes Receivable	13,814
Standard notes receivable | 0 - 90 Days
Financing Receivable, Past Due [Line Items]
Notes Receivable	1,030
Standard notes receivable | 91 - 180 Days
Financing Receivable, Past Due [Line Items]
Notes Receivable	608
Standard notes receivable | Greater than 181 Days
Financing Receivable, Past Due [Line Items]
Notes Receivable	12,176
Elevated risk notes receivable
Financing Receivable, Past Due [Line Items]
Notes Receivable	1,715
Elevated risk notes receivable | Total
Financing Receivable, Past Due [Line Items]
Notes Receivable	1,715
Elevated risk notes receivable | 0 - 90 Days
Financing Receivable, Past Due [Line Items]
Notes Receivable	0
Elevated risk notes receivable | 91 - 180 Days
Financing Receivable, Past Due [Line Items]
Notes Receivable	0
Elevated risk notes receivable | Greater than 181 Days
Financing Receivable, Past Due [Line Items]
Notes Receivable	$ 1,715

Allowance for Doubtful Accoun_6

Allowance for Doubtful Accounts - Schedule of Changes in Allowance for Notes Receivable (Details) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Accounts Receivables
Accounts receivable, Allowance for doubtful accounts, beginning balance	$ 50,794,000	$ 51,052,000
Write-Offs	(5,343,000)	(7,305,000)
Bad Debt Expense	3,960,000	2,779,000
Accounts receivable, Allowance for doubtful accounts, ending balance	49,411,000	46,526,000
Notes Receivables
Notes receivable, Allowance for doubtful accounts, beginning balance	14,790,000	16,749,000
Write-Offs	0	(2,809,000)
Bad Debt Expense	(1,109,000)	636,000
Notes receivable, Allowance for doubtful accounts, ending balance	13,681,000	14,576,000
Accounts and Financing Receivable
Allowance for doubtful accounts, beginning balance	65,584,000	67,801,000
Write-Offs	(5,343,000)	(10,114,000)
Bad Debt Expense	2,851,000	3,415,000
Allowance for doubtful accounts, ending balance	63,092,000	61,102,000
Accounts receivable recovered after write off	200,000	0
Standard notes receivable
Notes Receivables
Notes receivable, Allowance for doubtful accounts, beginning balance	13,607,000	13,258,000
Write-Offs	0	(9,000)
Bad Debt Expense	(1,065,000)	(256,000)
Notes receivable, Allowance for doubtful accounts, ending balance	12,542,000	12,993,000
Elevated risk notes receivable
Notes Receivables
Notes receivable, Allowance for doubtful accounts, beginning balance	1,183,000	3,491,000
Write-Offs	0	(2,800,000)
Bad Debt Expense	(44,000)	892,000
Notes receivable, Allowance for doubtful accounts, ending balance	$ 1,139,000	$ 1,583,000

Changes in Accumulated Other _3

Changes in Accumulated Other Comprehensive Income by Component - Summary (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Accumulated other comprehensive income
Beginning balance	$ 452,677	$ 480,461
Other comprehensive loss before reclassifications	(5,277)	(1,307)
(Gains) losses reclassified from other comprehensive income	8	36
Net current period other comprehensive (loss) income	(5,269)	(1,271)
Ending balance	446,637	493,102
Realized gain (less than)	100
Changes in other comprehensive (loss) income, tax expense (benefit)	1,400	300
Accumulated Other Comprehensive Income, net of taxes
Accumulated other comprehensive income
Beginning balance	4,000	5,563
Ending balance	$ (1,269)	$ 4,292

Changes in Accumulated Other _4

Changes in Accumulated Other Comprehensive Income by Component - Reclassification Adjustments (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Tax benefit	$ (4,452)	$ (8,299)
Net income	11,329	24,653
Realized Gains (Losses) on Sale of Available-for-sale Securities | Amounts Reclassified from Accumulated Other Comprehensive Income
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]
Losses from the sale of available-for-sale securities	(12)	(48)
Tax benefit	4	12
Net income	$ (8)	$ (36)

Property and Equipment (Details

Property and Equipment (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Total property and equipment, net		Total property and equipment, net
Operating lease — right-of-use assets	$ 33,446		$ 33,217
Total property and equipment, at cost	54,716		54,301
Less accumulated depreciation	28,014		26,199
Total property and equipment, net	26,702		28,102
Depreciation	2,900	$ 2,600
ROU Assets depreciation	1,600	$ 1,500
Housekeeping and dietary equipment
Property, Plant and Equipment [Line Items]
Property and equipment, gross	13,614		13,468
Computer hardware and software
Property, Plant and Equipment [Line Items]
Property and equipment, gross	5,976		5,880
Other
Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 1,680		$ 1,736

Leases - Additional Information

Leases - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Lessee, Lease, Description [Line Items]
Termination option	1 year
Reduction in ROU Assets due to cancellation	$ 0.9	$ 0.9
Reduction in Lease Liability due to cancellation	$ 0.2	$ 0.2
Minimum
Lessee, Lease, Description [Line Items]
Remaining lease term	1 year
Extension option	1 year
Maximum
Lessee, Lease, Description [Line Items]
Remaining lease term	7 years
Extension option	5 years

Leases - Components of Lease Ex

Leases - Components of Lease Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Lease, Cost [Abstract]
Operating lease cost	$ 1,386	$ 1,439
Short-term lease cost	355	167
Variable lease cost	82	72
Total lease cost	1,823	1,678
Weighted-average remaining lease term — operating leases
Operating cash flows from operating leases	$ 1,711	$ 1,583
Weighted-average remaining lease term — operating leases	4 years 4 months 24 days	5 years 7 months 6 days
Weighted-average discount rate — operating leases (as a percent)	4.20%	4.20%

Leases - Schedule of Future Min

Leases - Schedule of Future Minimum Lease Payments (Details) $ in Thousands	Mar. 31, 2022USD ($)
Leases [Abstract]
April 1 to December 31, 2022	$ 4,634
2023	4,956
2024	3,119
2025	1,396
2026	1,337
2027	1,363
Thereafter	1,505
Total minimum lease payments	18,310
Less: imputed lease payments	1,703
Present value of lease liabilities	$ 16,607

Goodwill and Other Intangible_3

Goodwill and Other Intangible Assets - Additional Details (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Measurement period adjustment	$ 0.7
Amortization of intangible assets	$ 1.2	$ 1
Customer Relationships
Finite-Lived Intangible Assets [Line Items]
Weighted average useful life (in years)	10 years
Trade Names
Finite-Lived Intangible Assets [Line Items]
Weighted average useful life (in years)	13 years
Patents
Finite-Lived Intangible Assets [Line Items]
Weighted average useful life (in years)	8 years
Noncompete Agreements
Finite-Lived Intangible Assets [Line Items]
Weighted average useful life (in years)	4 years

Goodwill and Other Intangible_4

Goodwill and Other Intangible Assets - Estimated Amortization Expense For Intangibles Subject To Amortization (Details) $ in Thousands	Mar. 31, 2022USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
April 1 to December 31, 2022	$ 3,642
2023	3,819
2024	2,685
2025	2,685
2026	2,665
2027	1,196
Thereafter	$ 2,895

Fair Value Measurements - Addit

Fair Value Measurements - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021	Dec. 31, 2021
Fair Value Disclosures [Abstract]
Unrealized losses on available-for-sale marketable securities, net of taxes	$ 5,300	$ 1,300
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Proceeds from available for sale municipal bonds	1,519	4,995
Unrealized losses related to equity securities	(4,100)
Unrealized gains related to equity securities		1,100
Manufacturer of prepackaged meals
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value adjustment	1,700
Significant Unobservable Inputs (Level 3) | Manufacturer of prepackaged meals
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred purchase payable (up to)	3,100		$ 4,800
Municipal bonds — available-for-sale
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Proceeds from available for sale municipal bonds	1,500	5,000
Realized loss (less than)	$ (100)	$ (100)

Fair Value Measurements - Marke

Fair Value Measurements - Marketable Securities and Deferred Compensation Fund Investments (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	$ 107,171	$ 114,396
Deferred compensation fund	39,012	46,691
Prepaid deferred compensation fund	6,300	7,000
Quoted Prices in Active Markets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	42,878	50,801
Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	2,428	2,882
Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	0	0
Carrying Amount
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	45,306	53,683
Total Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	45,306	53,683
Municipal bonds — available-for-sale
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	107,171	114,396
Municipal bonds — available-for-sale | Quoted Prices in Active Markets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Municipal bonds — available-for-sale | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	107,171	114,396
Municipal bonds — available-for-sale | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	0	0
Municipal bonds — available-for-sale | Carrying Amount
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	107,171	114,396
Municipal bonds — available-for-sale | Total Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Marketable securities	107,171	114,396
Money Market | Quoted Prices in Active Markets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	0	0
Money Market | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	2,428	2,882
Money Market | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	0	0
Money Market | Carrying Amount
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	2,428	2,882
Money Market | Total Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	2,428	2,882
Balanced and Lifestyle | Quoted Prices in Active Markets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	12,194	12,578
Balanced and Lifestyle | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	0	0
Balanced and Lifestyle | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	0	0
Balanced and Lifestyle | Carrying Amount
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	12,194	12,578
Balanced and Lifestyle | Total Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	12,194	12,578
Large Cap Growth | Quoted Prices in Active Markets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	16,206	20,358
Large Cap Growth | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	0	0
Large Cap Growth | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	0	0
Large Cap Growth | Carrying Amount
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	16,206	20,358
Large Cap Growth | Total Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	16,206	20,358
Small Cap Growth | Quoted Prices in Active Markets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	5,174	6,561
Small Cap Growth | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	0	0
Small Cap Growth | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	0	0
Small Cap Growth | Carrying Amount
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	5,174	6,561
Small Cap Growth | Total Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	5,174	6,561
Fixed Income | Quoted Prices in Active Markets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	4,414	4,826
Fixed Income | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	0	0
Fixed Income | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	0	0
Fixed Income | Carrying Amount
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	4,414	4,826
Fixed Income | Total Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	4,414	4,826
International | Quoted Prices in Active Markets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	1,719	2,299
International | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	0	0
International | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	0
International | Carrying Amount
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	1,719	2,299
International | Total Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	1,719	2,299
Mid Cap Growth | Quoted Prices in Active Markets (Level 1)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	3,171	4,179
Mid Cap Growth | Significant Other Observable Inputs (Level 2)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	0	0
Mid Cap Growth | Significant Unobservable Inputs (Level 3)
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	0	0
Mid Cap Growth | Carrying Amount
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	3,171	4,179
Mid Cap Growth | Total Fair Value
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Deferred compensation fund	$ 3,171	$ 4,179

Fair Value Measurements - Mar_2

Fair Value Measurements - Marketable Debt Securities (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2022	Dec. 31, 2021
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Amortized Cost	$ 108,778	$ 109,331
Gross Unrealized Gains	1,141	5,219
Gross Unrealized Losses	(2,748)	(154)
Estimated Fair Value	107,171	114,396
Credit Impairment Losses	0	0
Municipal bonds — available-for-sale
Fair Value, Investments, Entities that Calculate Net Asset Value Per Share [Line Items]
Amortized Cost	108,778	109,331
Gross Unrealized Gains	1,141	5,219
Gross Unrealized Losses	(2,748)	(154)
Estimated Fair Value	107,171	114,396
Credit Impairment Losses	$ 0	$ 0

Fair Value Measurements - Contr

Fair Value Measurements - Contractual Maturities of Debt Securities (Details) - USD ($) $ in Thousands	Mar. 31, 2022	Dec. 31, 2021
Fair Value Disclosures [Abstract]
Maturing in one year or less	$ 4,290	$ 5,606
Maturing in second year through fifth year	28,031	23,054
Maturing in sixth year through tenth year	44,174	52,180
Maturing after ten years	30,676	33,556
Total debt securities	$ 107,171	$ 114,396

Share-Based Compensation - Sche

Share-Based Compensation - Schedule of Stock-Based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total pre-tax stock-based compensation expense charged against income	$ 2,396	$ 2,271
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total pre-tax stock-based compensation expense charged against income	314	458
Restricted stock and restricted stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total pre-tax stock-based compensation expense charged against income	1,785	1,550
Performance stock units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total pre-tax stock-based compensation expense charged against income	199	96
Employee Stock Purchase Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total pre-tax stock-based compensation expense charged against income	$ 98	$ 167

Share-Based Compensation - Addi

Share-Based Compensation - Additional Information (Details) - USD ($) $ / shares in Units, $ in Millions	Jan. 04, 2022	Mar. 31, 2022	Mar. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost		$ 23
Period of expense of unrecognized compensation cost (in years)		3 years 6 months
Weighted average grant-date fair value of stock options granted (in dollars per share)		$ 4.06	$ 7.01
Aggregate intrinsic value of stock options exercised		$ 0.1	$ 0.4
SERP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares authorized for issuance (in shares)		1,000,000
Remaining shares authorized for issuance (in shares)		300,000
RSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)		391,000	300,000
Weighted average grant date fair value of stock granted (in dollars per share)		$ 18.10	$ 28.53
PSUs
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost		$ 1.9
Period of expense of unrecognized compensation cost (in years)		2 years 6 months
Granted (in shares)		60,000
Weighted average grant date fair value of stock granted (in dollars per share)		$ 21
Vesting period (in years)	3 years
DSUs | Non-employee member of the Board of Directors
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost		$ 0.1
Period of expense of unrecognized compensation cost (in years)		2 months 12 days
Granted (in shares)	1,000
Payout period (in years)	5 years
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for future grant (in shares)		2,000,000
Average weekly hours of work		20 hours
Requisite service period for plan participation eligibility		2 years
Stock options authorized to issue to employees (in shares)		4,100,000
2020 Omnibus Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock reserved for future issuance (in shares)		4,700,000
Shares available for future grant (in shares)		1,300,000
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period		10 years

Share-Based Compensation - Sc_2

Share-Based Compensation - Schedule of Stock Options Outstanding (Details) shares in Thousands	3 Months Ended
	Mar. 31, 2022$ / sharesshares
Number of Shares
Beginning of period (in shares) | shares	2,181
Granted (in shares) | shares	352
Exercised (in shares) | shares	(23)
Forfeited (in shares) | shares	0
Expired (in shares) | shares	(56)
End of period (in shares) | shares	2,454
Weighted Average Exercise Price
Beginning of period (in dollars per share) | $ / shares	$ 33.42
Granted (in dollars per share) | $ / shares	18.10
Exercised (in dollars per share) | $ / shares	17.50
Forfeited (in dollars per share) | $ / shares	0
Expired (in dollars per share) | $ / shares	21.68
End of period (in dollars per share) | $ / shares	$ 31.64

Share-Based Compensation - Assu

Share-Based Compensation - Assumptions for Fair Value of Options Granted (Details)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Share-based Payment Arrangement [Abstract]
Risk-free interest rate	1.50%	0.60%
Weighted average expected life	6 years 8 months 12 days	6 years 7 months 6 days
Expected volatility	36.60%	34.70%
Dividend yield	4.60%	2.90%

Share-Based Compensation - Summ

Share-Based Compensation - Summarized Information About Stock Awards (Details) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2022USD ($)$ / sharesshares
Outstanding:
Aggregate intrinsic value	$ 165
Weighted average remaining contractual life	5 years 4 months 24 days
Exercisable:
Number of options (in shares) | shares	1,697
Weighted average exercise price (in dollars per share) | $ / shares	$ 34.51
Aggregate intrinsic value	$ 0
Weighted average remaining contractual life	4 years

Share-Based Compensation - Sc_3

Share-Based Compensation - Schedule of Restricted Stock Units (Details) - RSUs - $ / shares shares in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Number
Beginning balance (in shares)	652
Granted (in shares)	391	300
Vested (in shares)	(181)
Forfeited (in shares)	(19)
Ending balance (in shares)	843
Weighted Average Grant Date Fair Value
Beginning balance (in dollars per share)	$ 31.03
Granted (in dollars per share)	18.10	$ 28.53
Vested (in dollars per share)	33.59
Forfeited (in dollars per share)	28.32
Ending balance (in dollars per share)	$ 24.55

Share-Based Compensation - Sc_4

Share-Based Compensation - Schedule of Outstanding Performance Stock Units (Details) - PSUs	3 Months Ended
	Mar. 31, 2022$ / sharesshares
Number
Beginning balance (in shares) | shares	35,000
Granted (in shares) | shares	60,000
Vested (in shares) | shares	0
Forfeited (in shares) | shares	0
Ending balance (in shares) | shares	95,000
Weighted Average Grant Date Fair Value
Beginning balance (in dollars per share) | $ / shares	$ 34.52
Granted (in dollars per share) | $ / shares	21
Vested (in dollars per share) | $ / shares	0
Forfeited (in dollars per share) | $ / shares	0
Ending balance (in dollars per share) | $ / shares	$ 26.01

Share-Based Compensation - As_2

Share-Based Compensation - Assumptions For Employee Stock Purchase Plan (Details)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate	1.50%	0.60%
Weighted average expected life (years)	6 years 8 months 12 days	6 years 7 months 6 days
Expected volatility	36.60%	34.70%
Dividend yield	4.60%	2.90%
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Risk-free interest rate	0.40%	0.10%
Weighted average expected life (years)	1 year	1 year
Expected volatility	36.90%	61.70%
Dividend yield	4.70%	2.90%

Share-Based Compensation - Defe

Share-Based Compensation - Deferred Compensation Plan (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
SERP expense	$ 2,396	$ 2,271
SERP
Defined Benefit Plans and Other Postretirement Benefit Plans Table Text Block [Line Items]
SERP expense	157	186
Unrealized (loss) gain recorded in SERP liability account	$ (3,785)	$ 1,301

Income Taxes (Details)

Income Taxes (Details) $ in Millions	Mar. 31, 2022USD ($)
Income Tax Disclosure [Abstract]
Impact of discrete tax items	$ 0.8
Unrecognized tax benefits	$ 0

Segment Information - Schedule

Segment Information - Schedule of Information of Reportable Segments (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2022USD ($)segment	Mar. 31, 2021USD ($)
Segment Reporting [Abstract]
Number of reportable segments | segment	2
Segment Reporting Information [Line Items]
Revenues	$ 426,811	$ 407,751
Income before income taxes	15,781	32,952
Corporate and eliminations
Segment Reporting Information [Line Items]
Income before income taxes	(14,051)	(15,263)
Housekeeping
Segment Reporting Information [Line Items]
Revenues	201,704	215,058
Housekeeping | Operating segments
Segment Reporting Information [Line Items]
Income before income taxes	20,399	28,167
Dietary
Segment Reporting Information [Line Items]
Revenues	225,107	192,693
Dietary | Operating segments
Segment Reporting Information [Line Items]
Income before income taxes	$ 9,433	$ 20,048

Earnings Per Common Share - Sch

Earnings Per Common Share - Schedule of Weighted Average Basic and Diluted Common Shares (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Numerator for basic and diluted earnings per share:
Net income	$ 11,329	$ 24,653
Denominator
Weighted average number of common shares outstanding - basic (in shares)	74,326	75,003
Effect of dilutive securities (in shares)	7	221
Weighted average number of common shares outstanding - diluted (in shares)	74,333	75,224
Basic earnings per share (in dollars per share)	$ 0.15	$ 0.33
Diluted earnings per share (in dollars per share)	$ 0.15	$ 0.33

Earnings Per Common Share - S_2

Earnings Per Common Share - Schedule Anti-dilutive Outstanding Equity Awards Under Share Based Compensation Plans (Details) - shares shares in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Earnings Per Share [Abstract]
Anti-dilutive (in shares)	3,369	1,694

Other Contingencies (Details)

Other Contingencies (Details)	3 Months Ended
	Mar. 31, 2022USD ($)covenant	Dec. 31, 2021USD ($)
Short-term Debt [Line Items]
Bank line of credit	$ 475,000,000
Long-term line of credit	$ 10,000,000	$ 0
Financial covenants | covenant	2
Reduction of bank line of credit	$ 81,000,000
Amount available under line of credit	384,000,000
Irrevocable standby letters of credit
Short-term Debt [Line Items]
Irrevocable standby letter of credit, outstanding	$ 81,000,000
LIBOR
Short-term Debt [Line Items]
Basis spread on variable rate	1.15%
Overnight Bank Funding Rate
Short-term Debt [Line Items]
Basis spread on variable rate	0.50%